Non-additive effects of age, MCI and APOE on measures of the attentional reorienting system by Strassegger, Peter
I 
 
 
 
Non-additive effects of age, MCI and 
APOE on measures of the 
Attentional Reorienting System 
 
 
 
Peter Strassegger 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main thesis – Department of Psychology 
 
UNIVERSITETET I OSLO  
 
29.04.2011 
 
 
 
 
II 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Peter Strassegger 
2011 
Non-additive effects of age, MCI and APOE on measures of the Attentional Reorienting 
System 
Supervisor: Thomas Espeseth 
http://www.duo.uio.no/ 
Trykk: Reprosentralen, Universitetet i Oslo 
III 
 
Abstract 
The current study investigates effects of normal aging, subjective/mild cognitive 
impairment (SCI/MCI) and apolipoprotein E gene (APOE) on different aspects of cognitive 
control. Cognitive control tasks were believed to be sensitive to distinguish normal aging vs. 
prodromal Alzheimer’s disease (AD) processes. 679 healthy participants aged 18-79 (M = 
48.2, SD = 18, Male/Female = 462/217), and 66 patients with diagnosis SCI/MCI aged 46-77 
(M = 60.7, SD = 6.8, Male/Female = 34/32) were recruited, screened for exclusion criteria, 
tested on psychometric tests (Stroop, Matrix Reasoning, Digit Symbol, Letter-Number Span, 
TMT A, TMT B) and three different neuropsychological experiments (1: covert visuospatial 
orienting task, 2: context processing/updating task, 3: visuospatial working memory). Based 
on previous findings, non-additive effects of MCI+APOE ε4 were expected only on measures 
that activate the attentional reorienting system, i.e. cost of invalid cues in experiment 1, and 
BX-trials in experiment 2. Separate ANOVAs in the analysis were conducted with Group 
(Young Control (YC) aged 18-45, Old Control (OC) aged 46-79, MCI, aged 46-77), and 
APOE (+ε4, ÷ε4) as between-subject factors, and different within-subject factors for all three 
experiments based on cognitive theory. Effects of normal age (OC ÷ YC) were contrasted to 
effects of MCI (MCI ÷ OC), and different patterns of results were revealed on different tests. 
On all psychometric tests a decline of normal aging was found, and MCI exacerbated the 
decline in an additive way, with no APOE involvements. On visuospatial working memory, a 
similar pattern was found, that is: MCI added to the decline of normal age, with no 
modulations of APOE. However, on predicted component measures in experiment 1 & 2, 
MCI patients showed a performances pattern that seemed to be different (non-additive) from 
normal age effects. These effects were modulated by APOE in the MCI group only, indicating 
that APOEε4 played a specific role in pathological aging effects on these measures believed 
to activate the attentional reorienting system. The attentional reorienting system is activated 
by unexpected but behaviorally relevant targets, and modulated by both ventral and dorsal 
frontoparietal networks in the brain (Corbetta, Patel, & Shulman, 2008). It was discussed 
whether measures of the attentional reorienting system may be interpreted as a cognitive 
endophenotype, being an intermediate step in the APOE-AD link. 
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1 Introduction 
1.1 Aging studies 
Cognitive control is believed to increase in efficiency, speed and complexity from 
childhood to young adulthood, but then declines as people get older or become demented 
(Craik & Bialystok, 2006; Parasuraman & Haxby, 1993). Normal aging is often characterized 
by reduced function of frontal brain networks, affecting cognitive control functions, such as 
perceptual speed, working memory, selective attention or executive function (Buckner, 2004; 
Craik & Bialystok, 2006). Alzheimer’s disease (AD) on the other hand, is commonly believed 
to affects functional integrity of medial-temporal regions of the brain, leading to progressively 
decline in episodic memory functions (Buckner, 2004). According to this view, early deficits 
in episodic memory are symptoms of prodromal AD (Dubois & Albert, 2004).  
However, AD is a neurodegenerative disease that leads to atrophy in several brain 
areas (Buckner, 2004), and very mild or very early AD has also been shown to be associated 
with decline in attentional orienting (Parasuraman, Greenwood, Haxby, & Grady, 1992) and 
executive working memory (Braver, Satpute, Rush, Racine, & Barch, 2005). Consistent with 
these findings, one may assume that early AD can be detected by measures of cognitive 
control as well. The APOEε4 allele is believed to increase the risk for people with MCI to 
develop AD (Wang, Hong, Lin, Liu, & Chen, 2010), and may modulate impairments in 
memory and attentional function for people with MCI (Thorvaldsson et al., 2010). On assays 
of visuospatial attentional reorienting, patients with mild dementia score worse than older 
controls (Parasuraman & Haxby, 1993), and APOE affect these measures in non-demented 
people, as healthy APOEε4-carriers score worse than healthy non-carriers (Greenwood, 
Sunderland, Friz, & Parasuraman, 2000). Thus, measures of cognitive control dysfunctions 
could be equally good, or better, predictors of incipient dementia or prodromal phases of AD 
(Negash et al., 2009; Parasuraman, Greenwood, & Sunderland, 2002).  
Based on available evidence, the believe of the current study is that normal aging and 
prodromal AD can be distinguished based on attentional and/or executive working memory 
task performance. The study will therefore investigate a wide specter of cognitive control 
tasks, and how they are influence by age, mild cognitive impairment (MCI) and the presence 
of ε4 polymorphism of APOE. A combination of MCI and APOEε4 may in this context be 
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interpreted as high risk for AD-development, and it is expected that this combination will be 
associated with severe impairments on attentional and/or executive working memory control 
tasks. 
1.1.1 Research questions and predictions 
679 healthy participants, aged 18-79, and 66 patients diagnosed with MCI, aged 46-77 
were recruited as part of a bigger project. All participants were genotyped for APOE and 
tested with an extensive battery of neuropsychological tests that are believed to measure 
diverse aspects of cognitive control (Stroop, Matrix Reasoning, Digit Symbol, Letter-Number 
Span, TMT A, TMT B). Further, three different behavioral assays generally believed to 
measure attentional/executive working memory control tasks were selected for this study 
(experiment 1 is believed to measure covert visuospatial attentional orienting task involving 
endogenous cues (Posner, 1980), experiment 2 is believed to measure context processing in a 
continuous working memory updating during stimulus discrimination task (Braver & Barch, 
2002), and experiment 3 is believed to measure visuospatial working memory maintenance 
and resolution in a delayed-match-to-sample task (Greenwood, Lambert, Sunderland, & 
Parasuraman, 2005)). A behavioral assays is defined as a measure based on cognitive theory, 
and believed to be more sensitive than standardized neuropsychological tests to measure 
specific cognitive component processes that are linked to specific functional networks in the 
brain (Greenwood, Lambert, et al., 2005). Together, these tests and assays made it possible to 
control and distinguish a wide specter of cognitive control functions and how these were 
affected by age, MCI and/or APOE. Based on previous findings (Ashendorf et al., 2008; 
Cohn, Dustman, & Bradford, 1984; Greenwood & Parasuraman, 2003; Greenwood, 
Parasuraman, & Haxby, 1993; Hart, Kwentus, Wade, & Hamer, 1987; Salthouse, Mitchell, 
Skovronek, & Babcock, 1989), additive main effects of age and MCI were expected on most 
performances. However, based theoretical considerations (Greenwood & Parasuraman, 2003; 
Parasuraman, et al., 2002), we expected to find interactions between MCI and APOE as well. 
Since previous studies primarily have found specific effects of early AD and APOEε4 on 
these subcomponent measures (Braver, et al., 2005; Greenwood, Lambert, et al., 2005; 
Parasuraman, et al., 1992), we predict to find non-additive effects of MCI and APOE only 
when the attentional reorienting system (Corbetta, et al., 2008) is activated, but not on other 
aspects of control functions. The hypothesis give rise to the following research questions: 
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1) Can we expect to find non-additive effects of MCI on behavioral assays that 
specific activate the attentional reorienting system?  
2) Can an APOEε4 modulation account for such a qualitatively difference?  
This introduction will first describe the difference between additive and non-additive 
effects. Then a general introduction of the currently used behavioral assays are given, 
including which processes they traditionally are believed to measure, and which 
neurophysiologic networks that are believed to be involved. For each experiment comments 
are given on whether previous studies have found additive or non-additive effects of AD-
related aging and/or APOE, as these findings gave rise to our predictions. After presenting 
these traditional interpretations, it will be argued how two specific subcomponents in 
experiment 1 & 3 also can be interpreted in terms of the attentional reorienting system.  
1.1.2 Definition: Additive vs. non-additive effects 
When comparing healthy aging groups with a pathology patient group on cognitive 
response pattern, it is often commented about whether the group difference is of a quantitative 
or qualitative manner (e.g. Braver, et al., 2005; Parasuraman, et al., 1992). In the current 
study, response patterns in the MCI group are compare with healthy young (YC) and old (OC) 
participants. MCI and OC groups are age-matched, and the only obvious difference between 
them is the presence of the MCI diagnosis. Effects of normal aging is therefore defined as 
(OC ÷ YC), and effects of pathology is defined as (MCI ÷ OC). If MCI is understood as an 
acceleration of normal aging, then a quantitative difference between MCI and OC are 
expected on all performances. A quantitative differences is for instance that reaction time 
decline when measuring (MCI ÷ OC) is similar/proportional to the decline when measuring 
(OC ÷ YC), or that the oldest individuals in the OC group show a response pattern similar to 
the MCI group. However, if MCI patterns stand out as something else than a acceleration of 
normal aging processes, a qualitative differences may be detected. A qualitative differences 
can for instance be that the difference between MCI and OC can be observed on other 
measures than difference between OC and YC (see Greenwood, et al., 1993). A quantitative 
difference between MCI and OC is in this study labeled an additive effect because the MCI 
diagnosis seem to “add” to the effect of normal aging. A qualitative difference between MCI 
and OC is labeled non-additive, because response patterns in the MCI group can not be 
understood in light of normal aging decline. According to the unitary factor framework of 
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aging (Buckner, 2004), one would mainly expect quantitative differences between people 
with MCI and age-matched healthy control participants. This framework indicate that the 
same factors that contribute to normal aging, also contribute to AD, and AD represents an 
acceleration of the same processes that lead to decline in normal aging (Buckner, 2004). As 
will be discussed later, this framework may be useful to understand the quantitative steady 
decline pattern between YC, OC and MCI on psychometric test scores and measures of 
visuospatial working memory. The multiple factor framework of aging on the other hand may 
be useful to understand non-additive effects, as it implies that the factors contributing to AD 
are different from factors contributing to normal aging, mainly because different brain 
systems are affected by AD and normal age process (Buckner, 2004). According to this 
framework, factors leading to normal aging are characterized by reduced function of frontal 
brain networks whereas factor leading to AD affects the functional integrity of temporo-
parietal regions of the brain. Each factor is associated with distinct causes, risk factors, 
anatomic targets, and cognitive consequences (Buckner, 2004), thus one would expect to find 
a non-additive effect of MCI on some measures of cognition.  
The next section will describe the behavioral assays that have been used to distinguish 
additive from non-additive effects, and which processes they are believed to measure. 
Traditionally, these three behavioral assays are believed to measure different information 
processes unit, i.e. attention and executive working memory respectively. After describing 
these traditional views, newer theories on how attentional and working memory processes 
may interact will be introduced, before it will be argued that two different component 
measures of respectively attentional and executive working memory function in fact may 
involve the same underlying networks, i.e. the ventral and dorsal frontoparietal networks 
associated with the attention reorienting system. 
1.1.3 Predictions based on three behavioral assays 
Experiment 1: Visuospatial Attentional Orienting. The first experiment in this 
study is believed to measure visuospatial attentional orienting. Posner and Petersen (1990) 
described the attentional system as an unified system for the control of mental processing. 
They believe the attentional system to performs operations separately from other mental 
performances (Posner & Petersen, 1990), and according to this view, a conceptual distinction 
is made between attentional and working memory functions. The attentional system according 
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to Posner and Petersen (1990) can be subdivided into three major functional units: orienting, 
detecting, and alertness/maintenance all carried out by different networks of anatomical 
areas. The first paradigm in this study was first developed by Posner (1980), and is often 
referred to as a cued letter discrimination task, where an arrow cue is used to direct a persons 
attention endogenously from one location to another (hence visuospatial attentional 
orienting). Visual orienting towards a sensory event can be done overtly, for example by 
direction eye or head toward the object, or it can be done covertly, that is by changing 
visuospatial attention without eye or head movement (Posner, 1980). The ability to shift 
attention covertly seems to be modulated by three different areas in the brain, the posterior 
parietal lobe, the superior colliculus, and the lateral pulivinar nucleus of the posterolateral 
thalamus, all appearing to have different functions (Posner & Petersen, 1990). Two of these 
functions are important for the current study: i.e. engagement vs. disengagement of attention.  
In the experiment participants are presented with arrow cues before asked to respond 
to a letters identity. A valid arrow cue will direct a persons attention to the right side of the 
visual field. Most cues are valid, but sometimes an invalid arrow appears that will directed 
participants attention to the wrong side and will therefore require a participant to redirect 
attention from one side of the visual field to another (Posner, 1980). The rational is that when 
measuring the reaction time following a valid cue, the persons ability to engage attention to a 
specific location is calculated, and when calculating the cost of an invalid cue, the persons 
ability to disengage/reorient attention from one location on the screen to another is measured 
(Posner, 1980). The superior colliculus and the pulivinar is believed to be involved in 
engagement of attention (Posner & Petersen, 1990), while the parietal lobe is believed to be 
involved in tasks of attentional reorienting (Posner, Walker, Friedrich, & Rafal, 1984). Thus, 
the first experiment in this study is believed to map functions associated with the posterior 
parietal lobe. There is evidence to suggest that the ability to engage attention in response to a 
valid cue is unaffected by aging (Greenwood, Parasuraman, & Alexander, 1997) or mild 
dementia (Parasuraman, et al., 1992). Measures of attentional reorienting on the other hand 
have shown to be sensitive for ageing (Greenwood, et al., 1993), mild dementia 
(Parasuraman, et al., 1992) and APOEε4 in healthy participants (Greenwood, Lambert, et al., 
2005). Indications were given that people with dementia are qualitatively different from age-
matched control (Greenwood, et al., 1993; Parasuraman, et al., 1992), and further that healthy 
APOEε4-carriers are qualitatively more similar to dementia people than healthy non-carriers 
6 
 
(Greenwood, et al., 2000). Thus, one may expect a non-additive effect of MCI+ε4 group on 
measures of attentional reorienting after an invalid cue to be revealed in the first experiment. 
Experiment 2 & 3: Working memory. The second and third experiment in this 
study are believed to measure of different aspects of working memory. Working memory may 
be defined as the ability to maintain and manipulate immediate available information 
(Buckner, 2004). Several subcomponents of the working memory function have been 
proposed, like the ability to keep information in an active state (up to 30 seconds), to allow 
manipulation like planning, reasoning, problem solving etc. on a “mental blackboard”, and to 
keep distracters out of this process for the period of active state (Barch et al., 2009; Reinvang, 
Winjevoll, Rootwelt, & Espeseth, 2010). Baddeley proposed a theoretical model for the 
working memory, dividing it in three subcomponents, 1) the visuospatial sketch pad, believed 
to be a short time buffer for visuospatial information, 2) the phonological loop, which is 
believed to store speech based information, and 3) the central executive function, which is a 
broader attentional controlling mechanism that guides manipulation of information (Baddeley, 
1992; Barch, et al., 2009). It is generally believed that the frontal lobe is involved in executive 
functions like planning or decision making, and this brain areas are the last to develop during 
childhood, and the first to be impaired in aging (Craik & Bialystok, 2006). In this study, the 
executive function of working memory is of most relevance, so the next section will describe 
experiment 2 and 3 in terms of which processes they are believed to measure, which 
neurophysiologic networks are believed to be involved, and which effects of age/MCI/APOE 
one may expect to find on these measures.  
The second experiment is generally referred to as the AX-CPT task (Braver, et al., 
2005). It is believed to measure a function referred to as context processing/updating (Braver 
& Barch, 2002; Braver, et al., 2005). Context processing/updating is the ability to represent 
the goal of a task while processing and responding to a stream of information, and thus a part 
of the attentional control function of working memory (Braver, et al., 2005). Context 
representation is defined as any task relevant information that a person has to represent 
internally in order to perform a task (Braver & Barch, 2002). In  short, the person has to 
respond to the letter X, but only after an A. Thus, an AX trial is the relevant target. A BX trial 
is one where B represents a invalid distracter (non-A), and requires the participant not to 
make a target response. The active maintenance of context information is believed to be 
mediated by the dorsolateral prefronal cortex (DL-PFC), while the dopamine (DA) 
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projections into the DL-PRF are believed to regulate access to context information (Braver & 
Barch, 2002). More specifically, DA are believed to filter what information is behaviorally 
relevant for the task, and which information is to be considered as noise (Braver & Barch, 
2002). Thus it is expected that people with damage in either DL-PFC or DA, or both, show 
impairments on measures of context processing. Neuropsychological studies have shown that 
responses in the AX-CPT are sensitive to normal aging (Braver & Barch, 2002), AD-related 
neuropathology (Braver, et al., 2005), and also to APOEε4 effects in healthy adults 
(Reinvang, Winjevoll, et al., 2010). When comparing healthy younger with older adults, older 
adults usually score worse than younger adults on trials in this task that involve an invalid 
cue, are infrequent, and behaviorally relevant (BX trials), especially after a long stimulus 
onset asynchrony (SOA) (Braver et al., 2001). Also AD-patients show this pattern, but 
previous studies have not found evidence for a non-additive effect of pathology (Braver, et 
al., 2005). However, this study did not include APOE as a factor. In the current study, additive 
main effects of age and MCI are expected, but possible non-additive interaction effects of 
MCI × APOEε4 will be explored, as this was predicted for experiment 1. 
The third experiment in this study measures visuospatial working memory. This is 
calculated along two dimensions of demand; load demand and distance demand. Load 
reflected the number of items participants had to remember, and distance reflected the ability 
to make correct spatial location distinctions (for details see the methodological section). This 
experiment does not involve distracters, but tested the ability to store visuospatial information 
for a short time, and the ability to compare that target location with a new type of spatial 
location information (i.e. spatial resolution). The latter ability may be seen as a process that 
involve more executive functions of working memory. Thus, this experiment is likely to 
involve executive functions in addition to rehearsal function, and one may assume that 
frontoparietal brain regions are involved in mediating performance on this task. Since normal 
aging is believed to cause changes in frontal lobe functions (Buckner, 2004), one may expect 
to find an age-related decline in working memory performance. Greenwood et al. (2005) 
tested healthy participants and found effects of age and APOE on these measures. Thus, 
effects of age and APOE in healthy participants are expected in this last experiment. 
However, Greenwood et al. (2005) did not include MCI as a factor in their analysis, and 
therefore possible non-additive interaction effects of MCI × APOEε4 will be explored also in 
this experiment.  
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Interaction between attention and working memory. Traditionally, 
experiment 1 is believed to measure visuospatial attention, while experiment 2 and 3 measure 
different aspects of executive working memory. This is consistent with general 
conceptualization indicate that the attentional function and the working memory function are 
different systems, mediated by different brain regions and modulated by different 
neurotransmission systems (Greenwood et al., 2008). The cholinergic system modulates the 
attentional system, and the noradrenergic and dopamergic neurotransmission system are 
believed to modulate functions of working memory (Greenwood, et al., 2008). However, it is 
also believed that these two functional systems interact, and newer evidence suggests for 
instance that certain working memory functions can be improved by cholinergic 
manipulations (Dani & Bertrand, 2007; Greenwood, et al., 2008). Thus, there is reason to 
believe that some aspects of the currently used experiments involve corresponding underlying 
neurological networks. 
There are several theories for how visuospatial attention and working memory may 
interact. Posner and Petersen (1990) believe that attentional alertness may be involved in the 
short time storage of information. Being in a high state of alertness affect how one can 
respond to a stimulus (Posner & Petersen, 1990), before storing information for a short time 
in working memory buffer (Baddeley, 1992). The alertness system can interact with other 
aspects of the attentional system, as it supports the visual orienting system by giving priority 
to the processing of different visual information (Posner & Petersen, 1990). Thus, Posner and 
Petersen propose a functional and anatomical connection between visuospatial attention and 
alertness attention, a function important for stimulus priority in the working memory. Also 
Baddeley (1993) argued that working memory involve more than memory processes. He 
discussed whether working attention could be used as term instead of central executive 
(Baddeley, 1993). Cowan et al. (2005) describe two components of attention as part of 
working memory: the control of attention and the scope of attention. Control of attention is 
conceptually similar to Baddeleys central executive and is important for information storage 
and processing (Cowan et al., 2005). The scope of attention is a conceptualization of the 
limited capacity of the focus of attention, in form of a typical short time storage of 3-5 chunks 
of information (Cowan, et al., 2005). Newer theories on working memory agree that 
visuospatial attention plays a central role in spatial working memory, but disagree on what 
specific role it plays (Greenwood, et al., 2008). Both studies on nonhuman primates and 
human subject support the idea that frontoparietal networks modulate short time storage of 
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location information (Awh, Anllo-Vento, & Hillyard, 2000), and since there seems to be a 
considerable overlap between frontal and parietal areas in both attentional and working 
memory task, one hypothesis for the interaction claims that the active maintenance of location 
information is mediated by attention-based rehearsal (Awh, et al., 2000). Thus, focal shifting 
of spatial attention may mediate the ability to maintain target locations in the spatial working 
memory (Awh, et al., 2000). Some evidence that support this attentional-based rehearsal 
hypothesis come from interference studies. For instance, in a study conducted by Smyth 
(1996), subjects were asked to maintain spatial information for a short period of time, after 
which the they were distracted by a spatial and an auditory cue. The spatial, but not the 
auditory cue interfered with spatial working memory, thus leading to the conclusion that when 
spatial working memory is interfered by covert shifts of  spatial attention, performance 
declines (Smyth, 1996).  
In sum, this means that both conceptual considerations and empirical findings indicate 
that aspects of the working memory and the attention system interact, both involving 
frontoparietal networks. In the current study, participants were tested on 3 different behavioral 
assays that traditionally are believed to measures different systems, thus leading to 3 different 
predictions of how aging, MCI and APOE may influence these measures. However, one may 
claim that some components of the current assays can be interpreted to measure the same 
underlying processes, involving the same networks. Both invalid cue trials in experiment 1, 
and BX trials in experiment 3 can be understood in terms of how they activate ventral and 
dorsal frontoparietal networks of the attentional reorienting system. The next section will 
argued how this may be claimed.  
1.1.4 New understanding of subcomponents in Experiment 1 & 2: 
The Attentional Reorienting System 
The attentional reorienting system is described as a complex set of adjustments when a 
novel or unexpected stimuli requires a change in the course of action, and involves 
interactions between dorsal and ventral frontoparietal networks (Corbetta, et al., 2008). 
Attentional reorienting may occur between two or more environmental stimuli, and the object 
to reorient towards has to be salience or behaviorally relevant (Corbetta, et al., 2008). The 
dorsal network is activated in goal driven tasks (Corbetta, et al., 2008) for instance after many 
valid cues or an AX trials. The ventral network will interrupt the dorsal network when 
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expectations are violated and an object sharing features with the relevant target are detected 
outside current awareness (Espeseth et al., in press). Possible candidates for this activations 
are stimuli in the oddball paradigm, as evidence from an ERP-study suggest that regions 
associated with ventral networks are activated by unexpected, task relevant oddball stimuli 
(Espeseth, et al., in press). Also BX trials in experiment 2, and invalid cue trials in experiment 
1 can be interpreted as infrequent and unexpected, but still behaviorally relevant stimuli. Thus 
one may assume them to activate the attentional reorienting system as well. Experiment 3 and 
psychometric tests on the other hand are other measures of cognitive control, not specifically 
involving infrequent, unexpected but behaviorally relevant targets, and thus we do not expect 
them to be measures of the attentional reorienting system. Do we expect specific non-additive 
effects of MCI and APOE on measures of attentional reorienting? As mentioned above, 
previous studies have found effects of age and pathology on both paradigms (Braver, et al., 
2005; Greenwood, et al., 1993; Parasuraman, et al., 1992), and a qualitative difference was 
only reported after invalid arrow trials (Parasuraman, et al., 1992). Espeseth et al. (in press) 
also found APOE modulations on ERP-amplitudes associated with attentional reorienting 
processes, where ε4-carriers had lower P3a amplitudes than non-carriers. Taken together, 
there is reason to believe that invalid arrow trials in experiment 1 and BX trials in experiment 
2 are aspects of one general attentional reorienting system, that involves both ventral and 
dorsal frontoparietal network activation (Corbetta, et al., 2008), as both share features relevant 
for this activation (unexpected, but behaviorally relevant targets). As previous studies have 
found specific effects of mild dementia and APOEε4 primarily on measures believed to 
activate the attentional reorienting system, we predict to find non-additive effects of MCI only 
when the attentional reorienting system is activated. 
After presenting results in this study, the general discussion will then ask if one can 
argue that the attentional reorienting system is an endophenotype, being a intermediate step 
between APOE and AD. But, before turning to the results, important limitations associated 
with studies involving APOE and MCI will be described in the next section. 
1.1.5 MCI and APOE 
When examining the effect of healthy aging compared to pathological aging, it is often 
difficult to obtain a sample of older adults free from the disease (Buckner, 2004). Healthy 
older people may be in a stage of pathological development (because of deposits of amyloid 
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plaques and neurofibrillary tangles) even though no signs of pathology are indicated by 
cognitive performances (Braak & Braak, 1991). Thus, in the current study one cannot expect 
to find diametric differences between people with MCI and healthy age-matched controls, 
because some of the healthy older adults may in fact be in a stage of pathological 
development. Also, because MCI diagnosis forms a heterogeneous group with unstandardized 
diagnostic classifications, it may be hard to determine boundaries between normal aging 
groups and MCI groups (Nordlund et al., 2005). People with MCI usually have normal global 
cognitive functions and intact daily living abilities, but experience subjectively cognitive 
deficit usually associated with decline in language, attention or executive function (Grambaite 
et al., 2011). Amnestic MCI, a subcategory of the MCI diagnosis, is associated with objective 
impairment in memory performance or both memory and other cognitive performances 
(Grambaite, et al., 2011). The majority of patients with MCI are called progressive MCI 
(pMCI) because they will develop AD, but some remain stable in a preclinical phase and are 
therefore called non-progressive or stable MCI (sMCI) (Vannini, Almkvist, Dierks, Lehmann, 
& Wahlund, 2007), but these impairments do not meet criteria for dementia (Petersen et al., 
2001). Different types of biological markers may increase risk for AD development like 
cerebrospinal fluid (CSF) markers amyloid β-proteins 42 (Aβ42), or phosphorylated-tau level. 
The ε4 allele of the APOE gene is also concerned to be such a biological marker for increased 
AD-risk (Mahley, 2006; Wang, et al., 2010; Ye, 2005).  
The APOE gene is found on chromosome 19 and occurs in three alleles (ε2, ε3, ε4). In 
a general population, the frequency of ε2 allele is about 5-10%, the ε3 allele about 60-70%, 
and ε4 between 15-20% (Mahley, 2006; Uterman, Langenbeck, Beisiiegel, & Weber, 1980). 
The APOE gene is believed to be involved in modulations of neuronal repair and plasticity, 
and hence believed to have a broad effect on cognition (Greenwood & Parasuraman, 2003). 
The APOE gene produces a plasma protein that is involved in the transportation of lipids like 
cholesterol and other hydrophobic molecules in the central nervous system, and redistributes 
these lipids among cells throughout the body (Fagan et al., 1999; Greenwood & Parasuraman, 
2003; Mahley, 2006). The proteinproduct of APOE plays a role in synaptic development 
(Mauch et al., 2001), and in clearance of cholesterol and other lipids from a site of injury, thus 
playing a role in long term plasticity changes following an injury (White, Nicoll, & 
Horsburgh, 2001). When intermediate steps between genotype and cognitive phenotype (i.e. 
endophenotypes) are considered, it is thought that gene variations can affect cognition 
through a number of pathways (Greenwood & Parasuraman, 2003). An APOE gene has many 
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functions in the nervous system, and it is generally believed to interact with many 
demographic, biological and pathological variables, all with multiple consequences for 
cognition (Reinvang, Winjevoll, et al., 2010). The effect of APOE on cognition seem to be 
different in old and young age (Bondi, Salmon, Galasko, Thomas, & Thal, 1999; Mondadori 
et al., 2007; Turic, Fisher, Plomin, & Owen, 2001). With respect to AD development, one of 
the main arguments for how APOE is related to degenerative diseases like AD, is that it 
modulates the way the brain responds to injurious insults like oxidative stress, ischemia, 
excess amyloid beta production, inflammation, or normal aging process itself (Mahley, 2006). 
It is believed that the processes of neuronal maintenance and repair are effective in APOEε3 
and APOEε2-carriers, but impaired in APOEε4-carriers (Greenwood & Parasuraman, 2003; 
Mahley, 2006). Previous studies have shown that Aβ42 and APOE may interact and influence 
cognitive control performance in people diagnosed with MCI (Thorvaldsson, et al., 2010). 
However, APOE is just a vulnerability-gene, and being a homozygote ε4 carrier is not 
sufficient for the development of AD (Henderson et al., 1995). By age 90, only half of the 
homozygote ε4-carriers have developed AD (Henderson, et al., 1995), and only 60% of 
people diagnosed with AD (either clinically or postmortem) are believed to be ε4-carriers 
(Mayeux et al., 1998). This indicated that APOE genotyping is not sensitive and specific 
enough to be used as a diagnostic test for AD (Mayeux, et al., 1998). Furthermore, there is 
evidence to suggest that being carriers of  the ε4 allele increases the risk for developing AD 
only up to a certain age, and after this peak the risk declines (Breitner et al., 1999).  
In sum, when interpreting effects of polymorphic variations of APOE, cautions need to 
be taken because of the general effect APOE has in the nervous system, and because the effect 
of APOE on cognition may go through different biological pathways all having different 
interacting effects on cognition. Thus, as APOE may interact with many other variables and 
influence cognition differently in different time of age, results in this study have to be 
interpreted with care. 
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2 Study 1: Psychometric Test Scores 
2.1 Predictions 
The first part of the study was to examine how age, MCI and APOE affected 
participants scores on different psychometric tests believed to measure aspect of cognitive 
control. We predicted that main effects of age and MCI would indicate an additive decline of  
normal aging and MCI on all aspects that measured cognitive control. However, previous 
studies have reported effects of APOEε4 on executive functions like TMT B or operation 
span, and on episodic memory, but not on perceptual speed tasks like digit symbol (Small, 
Rosnick, Fratiglioni, & Bäckman, 2004). We expect therefore to find some effects of APOE, 
but do not expect specific interactions between APOE and MCI leading to non-additive 
decline. 
2.2 Method 
2.2.1 Healthy control participants 
A total of 679 healthy people ranging from 18 to 79 years of age (M = 48.2, SD = 18) 
were recruited for this study (see table 1 for demographics). Most of the healthy control 
participants in the control group were recruited through advertisements in local newspapers. 
Some of the younger participants were students and recruited from different classes at the 
University of Oslo. The project was approved by the Regional Committee for Research Ethics 
of South-Eastern Norway. Participants’ consent was obtained according to the Declaration of 
Helsinki (World Medical Assembly, 2008). All participants were screened for previous and 
present neurological diseases, psychiatric disorders, depression, cancer, chronic illness, 
substance abuse, sensory or motor impairments all being conditions known to affect the 
central nervous system. The presence of, or formerly treatment of any of these conditions was 
used as an exclusion criteria. Healthy candidates were first interviewed by phone according to 
a checklist about health and previous illness or injuries. Participants had to be native speakers 
of Norwegian and have completed obligatory basic education without diagnosed reading or 
learning disorders. Persons on adequate medication for hypertension, diabetes or 
hypercholesterolemia were not excluded. Participants were not allowed to consume nicotine 
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or caffeine during the test period or in the lab premises, but were not required to abstain from 
these substances prior to attendance. All participants read an information sheet and signed a 
statement of informed consent approved by the regional ethical committee for medical 
research. All participants completed Beck’s Depression Inventory (BDI) (Beck, 1996) as a 
measure of the presence of symptoms of depression (≥ 13 cut-off criteria for exclusion), as 
well as screening on the Mini-Mental State Examination (MMSE) (Folstein, Folstein, & 
McHugh, 1975) to exclude participants by ≥ 26 cut-off criteria. 
2.2.2 MCI patients 
66 patients diagnosed with MCI (aged 46-77, M = 60.7, SD = 6.8) were recruited by 
our collaborators at Akershus University Hospital, a memory based university clinic, between 
September 2005 and January 2010. The inclusion criteria were cognitive symptoms and 
subjective complaints lasting longer than 6 months, preserved general intellectual function, no 
or very mild activities of daily living problems (ADL) and Global Deterioration Scale (GDS) 
score of 2 or 3 (Reisberg, Auer, & Monteiro, 1997; Reisberg, Ferris, de Leon, & Crook, 
1988). Diagnosis subjective and mild cognitive impairment (SCI and MCI) (Gauthier et al., 
2006; Petersen et al., 1999) were determined from a clinical interview and screening tests, as 
well as a screening cut-off  ≥ 26 on the Mini-Mental State Examination (MMSE) (Folstein, et 
al., 1975). All participants were given neuropsychological tests (see below) and rated on a 
standardized protocol. Criteria for exclusion were established psychiatric disorder, cancer, 
drug abuse, solvent exposure, or anoxic brain damage. The project was approved by the 
South-Eastern Norway committee for medical research ethics. The MCI sample was stratified 
according to normal or pathological levels of free flowing amyloid β-proteins 42 (Aβ42), 
Total-tau (t-tau), and phosphorylated-tau (ph-tau) in cerebrospinal fluid (CFS) extractions, 
stratification procedures established by age-specific cut-off values (Sjogren et al., 2001). For 
more detailed information about MCI patients recruitment and screening procedures, see 
Grambaite et al. (2011).  
After screening, all participants (MCI and healthy controls) gave their informed 
consent to their participation, including blood sampling, DNA extraction, genotyping and the 
storage of the remaining blood for up to 10 years in a biobank according to Norwegian 
regulations. The biobank was approved by the Norwegian Department of Health. 
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Table 1 Demographics   
 
NB! MMSE and BDI data for MCI group are missing in this study due to problems with data coordination.  
2.2.3 DNA Extraction and Genotyping 
DNA extraction and genotyping procedures was conducted initial in the start of this 
project. Specific details about genotyping procedures, which laboratories were involved, 
methods used etc. can be found in an article by Espeseth et al. (2006). Following 
identification of the genotypes of each participant, the total sample was subdivided into two 
genotype groups: (1) APOEε4 carriers (including ε3/4,  ε4/4, ε2/4) (2) APOEε4 non-carriers 
(including  ε2/2, ε2/3, ε3/3). 
2.2.4 Statistical Analysis 
All analysis in this study were conducted with SPSS (PASW) Statistics 18, all p’s 
reported are Greenhouse-Geisser values. Participants were tested on Matrix reasoning, 
Wechsler Memory Scale (WMS) and Vocabulary and subscales of the Wechsler Abbreviated 
Scale of Intelligence (WASI) (Wechsler, 1999) on tests of psychomotor speed, attention and 
executive functions (Trail Making A and B, WAIS-R Digit Symbol, D-KEFS Stroop Color 
Word (Delis, 2001)), and on California Verbal Learning Test II (CVLT-II) (Delis, 2000). 
Scores on Vocabulary, WMS & CVLT-II were excluded in this current study, because they 
are not believed to measure cognitive control functions. Participants were divided into three 
groups; young control (YC): 18-45 years, N = 265 (M = 28.4, SD = 8, Male/Female = 
182/83), old control (OC): 46-79 years, N = 414 (M = 61.3, SD = 8.3, Male/Female = 
280/134), and MCI group: 46-77 years, N = 63 (M = 60.7, SD = 6.8, Male/Female = 34/32). 
Participants were also divided according to genotype, APOE (ε4-carrier (N = 269), non-
carrier (N = 470). APOE was analyzed as a dichotomy variable and not in a three dose manner 
(non-carriers, heterozygote carriers, homozygote carriers), because a dose analysis would 
leave too small groups under certain conditions, for instance the MCI ε4/4 carriers would only 
contain 5 participant. Group (3) and APOE (2) were submitting as fixed factors in univariate 
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ANOVAs, with different psychometric test scores as separate dependent variables. Gender 
was submitted as covariate for all tests. Not all participants performed all tests. Total number 
of participants of each tests were: Matrix Reasoning (N = 735), Digit Symbol (N = 680), 
Letter-Number Span (N = 547), California Verbal Learning Test II (N = 672), Trail Making A 
(N = 544), TMT B (N = 541) and Stroop test (N= 730). Because of uneven gender distribution 
in our groups, a non-parametric follow up analysis for chi-square goodness-of-fit was 
conducted to compare observed gender distribution with expected gender distribution in all 
three groups. Expected gender distribution, based on official Norwegian non-stratified 
population count pr. January 2011 (Statistisk sentrabyrå, 2011) was approximately 50/50 
(2.460.849 men vs. 2.459.456 women). Chi-square goodness-of-fit analysis were conducted 
for all participants, and for each group separately. Analysis with CSF-measures were not 
included, as these were outside of the scope of the predictions in this thesis. 
2.2.5 Results 
As table 2 shows, the MCI group increased the overall decline observed between YC 
and OC in an additive way. No APOE effects were found in any of the tests.  
Table 2 raw scores on all psychometric tests and statistical values
 
Matrix Reasoning. As this test is believed to measure fluid intelligence in relation  to 
adaptive functions, and believed to decline due to age and dementia related brain impairments 
(Ryan et al., 2005), we expected to find a similar decline due to age and MCI. A rather strong 
effect of Group was found, F(2,738) = 219.7, p < .0005, η²p = .376. due to additive decline of 
age and MCI. This effect did not vary due to gender, when gender was submitted as a 
covariate (p = .086). 
Digit Symbol (WASI-R). This test is primarily meant to measure motor speed 
performance, but some aspects of memory also make a contribution to performance on this 
test (Joy, Kaplan, & Fein, 2004). Further, test performance on Digit Symbol is believed to 
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decline due to age and reflect a general age related slowing of processing capacity (Salthouse, 
1996), and MCI patients have been shown to score below age-matched healthy control (Hart, 
et al., 1987; Nordlund, et al., 2005). We found test performance slowed due to age and MCI, 
qualified by a main effect of Group, F(2,673) = 138.9, p < .0005, η²p = .292. However, this 
effect seemed to be influenced by gender, due to significant covariate interaction (p = .025), 
as performance pattern were in favor of men (M = 56.6 vs. M = 54.5). 
Letter-Number Span. Main Effect of Group, F(2,540) = 63.37, p < .0005, η²p = .19 
indicated that this working memory performance also declined due to age and MCI in an 
additive way, as seen in figure 1.1. Gender did not seem to influence this effect (p = .112) 
Trail Making Test. Both time on TMT A and B, and error scores on TMT B are useful 
to distinguish normal aging effects from MCI and AD effects (Ashendorf, et al., 2008). Main 
effects of Group were revealed on TMT A, F(2,537) = 81.76, p < .0005, η²p = .233, indicating 
a steady increase in RT. This effect did not vary due to gender (p = .821). Also for TMT B a 
main effect of Group was found, F(3,534) = 87.3, p < .0005, η²p = .246 , and this effect was 
similar for both genders (p = .832). Figure 1.2 indicate that RT in TMT B increase steady due 
to age and MCI.  
Figure 1.1 & 1.2 Main Effect Group on Letter-Number Span & Trail Making B 
 
Stroop. Especially color naming (Stroop  1) and interference task (Stroop 3) have been 
shown to be sensitive to effects of aging (Cohn, et al., 1984), and MCI scores are believed to 
be below age-matched control (Nordlund, et al., 2005). We found main effects of Group with 
p’s <.0005 on all Stroop condition (Stroop 1: η²p = .101, Stroop 2: η²p = .083, Stroop 3: η²p = 
.182, Stroop 4: η²p = .175). Figure 1.3 show how MCI effect is additive to normal age effect 
on all measures of Stroop. Stroop condition did not vary due to gender (p’s > .233). 
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Figure 1.3 Main Effect Group on Stroop Tests
 
Chi-square goodness-of-fit follow up. Chi-square follow up analysis revealed that 
overall our sample contained more men than expected (67% men, 33% women), χ2 (1, 801) = 
93.045, p < .0005. Both the YC and OC group had more men and less women than expected 
(68.5% vs. 31.5% for YC, and 67.5% vs. 32.5% for OC), while in the MCI group gender 
distribution was equal (51.5% men, 48.5% women).  
2.2.6 Discussion 
Indications are given that all psychometric test used showed a pattern of decline due to 
age and MCI, consistent with a view of MCI being an additive burden to normal aging. No 
main effects or modulations of APOE were found in any of the psychometric tests. Gender did 
however affect some of the results in significant covariate interactions, and this may influence 
the generality of these findings. Chi-square goodness-of-fit analysis revealed that compared to 
what is expected, our sample had an overrepresentation of men and underrepresentation of 
women in healthy groups, thus indicating that our results may be more representational for 
men than women in healthy groups. However, the MCI group had an expected distribution of 
gender. 
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3 Experiment 1: Visuospatial 
Attentional Orienting 
3.1 Background and Predictions 
We predict that performance associated with a MCI diagnosis adds to the decline 
associated with normal aging on all measures of visuospatial attention that do not activate the 
attentional reorienting system (i.e. valid, neutral, no cue conditions). Second, we predict that 
an interaction between MCI and APOEε4 resulting in a non-additive effect on measures that 
involved attentional reorienting system (i.e. invalid cue condition). The next section it will 
describe how one can make such specific predictions, based on previous results. 
This experiment uses centrally placed cues to indicate in a symbolic way where the 
target information will be located. Paradigms like this one are believed to elicit top-down 
processes for spatially attentional orienting (Festa-Martino, Ott, & Heindel, 2004). Attentional 
impairments in AD patients is commonly believed to be because of damages in the parietal 
lobe (Parasuraman, et al., 1992; Posner, et al., 1984), or decline in cholinergic integrity 
(Sarter & Bruno, 2004). It has been speculate if decline in cholinergic density may predict 
dementia progression, because pathological deposits of amyloid plaques and elevated tau 
levels have been shown to accelerated decline in cholinergic integrity (Sarter & Bruno, 2004). 
Taken together, one may expect to find that patient diagnosed with MCI score worse than age 
matched healthy older adults on overall attentional reorienting measures, and old control 
score worse than young control. However, previous studies have discussed whether 
performance of old control and pathology groups are qualitatively or quantitatively different 
(Parasuraman, et al., 1992). What makes out a qualitative difference? There are many ways to 
define qualitative vs. quantitative differences between people with mild dementia and healthy 
controls. Greenwood et al. (1993) addressed this question by examining RTs after valid and 
invalid cues, and asked if healthy aging groups (age 19 – 79) performance were different 
compared to response patterns obtained from people with dementia in an earlier study (mean 
age: 71.8, SD = 2.4) (Parasuraman, et al., 1992).  In this earlier study, Parasuraman et al. 
(1992), found that visuospatial attention in mild demented people was impaired only 
following an invalid cue and not following a valid cue. Further, this impairment was linked to 
hypometabolism in the superior parietal lobe in the right hemisphere, indicating that the 
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impairment of AD was specific rather than global (Parasuraman, et al., 1992). Parasuraman et 
al. (1992) also included age-matched controls (mean age: 70.7, SD = 2.2) and concluded that 
there may be a qualitatively difference between healthy aged and demented people in 
responses following a invalid cue. Greenwood et al. (1993) examined further which factors 
may contribute to a qualitatively difference in these response patterns, and implemented two 
tasks on their young and old healthy control groups, 1) a target discrimination task with 
central cues (endogenous) and 2) a target detection tasks with peripheral cues (exogenous). 
They found that age difference only became eminent in the discrimination task, as older 
participants differed from younger participants on RTs for the cost of an invalid cue after a 
long SOA conditions. On this invalid, long SOA condition, healthy old participants performed 
better than demented patients, but also that patients with mild dementia had impairments on 
cue detection task, especially after long SOA (Greenwood, et al., 1993). The authors 
concluded that this difference in performance indicated a qualitatively difference 
(Greenwood, et al., 1993). Taken together, these studies imply that SOA and cue validity may 
be good variables to detect different pattern of performance between normal aging groups and 
mild dementia groups. In the current study the terms additive vs. non-additive are used 
difference to describe if effects of MCI are exacerbations of normal aging effects, or if the 
effect of MCI is something else. As an endogenous discrimination task was implemented, 
SOA and cue validity were used as variables to distinguish response patterns between young 
control, old control and MCI groups. We expected that the cost of an invalid cue after long 
SOA is a plausible candidate for discriminating possible non-additive effects when comparing 
MCI with OC, and OC with YC. But what about the predicted modulation of APOE? 
In later years Greenwood et al.(2000) found that healthy APOEε4 carriers showed 
greater cost of invalid cues compared to healthy non-carriers  (Greenwood, et al., 2000). 
Although the Cost Effect was not as large as for individuals with mild dementia, the APOEε4 
carriers showed deficit in visuospatial attention that was qualitatively the same as deficits 
associated with individuals with mild dementia (Greenwood, et al., 2000). The debate 
concerns whether these APOE modulations in healthy adults is part of a prodromalphase of 
AD, or whether it can be seen as a cognitive phenotype of APOE, independently of AD 
(Greenwood, Sunderland, Putnam, Levy, & Parasuraman, 2005; Negash, et al., 2009). 
Another question is how APOE may affect the attentional system. One hypothesis claims that 
APOEε4 affect attention through modulations of the cholinergic system (Parasuraman, et al., 
2002). Support for this hypothesis comes from molecular biology, psychopharmacological 
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approaches, animal studies, behavioral and neuroimaging studies (Everitt & Robbins, 1997). 
The parietal lobe integrates cholinergic projections, and the efficiency of attentional 
performances may be dependent on how those projections are integrated in the parietal cortex 
(Everitt & Robbins, 1997). Prior to clinical diagnosis of AD, decline of metabolic activity and 
blood flow in the parietal lobe has been found in APOEε4 carriers (de Leon et al., 2001). 
Thus, there is evidence supporting the hypothesis that APOE may influence the reorienting of 
visuospatial attention in healthy middle aged APOEε4 carriers, and further in people with 
mild dementia, probably because of decline in cholinergic integrity (Sarter & Bruno, 2004).  
In light of the described evidence, we expect to find different response pattern for 
people with MCI and age-matched healthy participants when measuring the cost of invalid 
cue. This difference is expected to develop further as SOA increases, and due to the presence 
of an APOEε4 allele. Further, as the MCI+ε4 group is believed to be at higher risk for AD-
development, and because they are general believed to have greater impairments in the medial 
and parietal lobe (Buckner, 2004), one may expect them to show response patterns that may 
be different compared to normal aging effects. Because previous findings have indicated that 
non-additive effects primarily are found on invalid target trials, and because invalid trials are 
believed to activate frontoparietal networks associated with attentional reorienting system 
(Corbetta, et al., 2008), we predict a non-additive effect for the MCI+ε4 group specifically for 
invalid arrow trials. Other cue trials (valid, neutral, no cue) are not believed to activate the 
attentional reorienting system, and thus we do not predict non-additive effects of MCI in 
combination with APOEε4 on these trials.  
3.2 Method 
3.2.1 Stimuli and Procedure 
A cued visual discrimination task based on Posner (1980) cued detection task was 
used. Stimuli were presented on an EIZO 21-in. CRT monitor, and the experimental paradigm 
was controlled and responses collected by the E-Prime software (Schneider, Eschman, & 
Zuccolotto, 2002). After a fixation cross (0.45° × 0.45°) was presented centrally on the 
computer screen for 500ms, a centered arrow cue (1.35° × 0.8°) pointing left, right or in both 
directions was presented.  Also a no cue condition was used. Target consisting of vowels (A,E 
or U) or consonants (T, D or R) (0.8° × 1.0°, font Tahoma Bold) were presented 6.7° left or 
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right of the fixation point. The arrow cues were presented at two different target stimuli onset 
asynchronies (500 and 2000ms). This varied with blocks of trials. Each block consisted of 96 
trials and contained 48 valid trials (50%) and 16 trials (16.67%) for each of the other cue 
conditions. All stimuli were presented in black on a white background. Participants were 
seated in front of the computer monitor after finishing the informed consent, and the 
neuropsychological test procedures. An instruction appeared on the screen, and was read out 
loud for the participant before the practice block started, consisting of 36 trials. Participants 
were asked to make a categorization of the target letters, pressing the leftmost key with the 
left index finger on an E-Prime compatible response box as fast and as accurate as possible if 
the letter was a vowel, and the rightmost key with the right index finger if the letter was a 
consonant. Each trial began with a fixation cross, followed by a variable SOA, the cue, and 
finally the target letter. If the participants responded correctly to the target letter, they were 
notified in terms of the word Riktig! (“correct”) which was being presented 4° above the 
center of the screen for 1 second. The participants were given an opportunity for a short break 
between each block. The whole experiment lasted roughly for 35-40 minuets 
3.2.2 Participants and Genotyping 
For recruitment, screening, exclusion and genotyping see study 1.  
3.2.3 Statistical Analysis 
Participants were divided into three groups; young control (YC): 18-45 years, N=262, 
old control (OC): 46-79 years, N=414, and MCI group: 46-77 years, N = 63. An initial 
omnibus, repeated measures ANOVA on Accuracy Response was conducted, with Cue 
Validity (Invalid, Valid, Neutral, No Cue) and SOA (500ms, 2000ms) as within-subject 
factor, and Group (YC, OC, MCI) and APOE-genotype (ε4-carriers, ε4-non-carriers) as 
between-subject factors. The distribution of participants were as following: YC+ε4 (N=85), 
YC÷ε4 (N=177), OC+ε4 (N=157), OC÷ε4 (N=257), MCI+ε4 (N=27), MCI÷ε4 (N=36). No 
follow-up analysis on accuracy measures were carried out, because Accuracy Rate was very 
high. The second omnibus ANOVA measured Reaction Time (RT) for each condition. An 
omnibus ANOVA with these factors can give important information about how group 
differences affected measures on Cue Validity, and about possible modulations on Cue 
conditions. The effect of aging (OC ÷ YC), can be contrasted to the effect of diagnosis (MCI 
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÷ OC) on all Cue Condition interactions. Separate univariate follow up for each Cue condition 
(Invalid, Valid, Neutral, No Cue) was conducted with Group and APOE as fixed between-
subject factors, and SOA as within-subject factor, aimed to get detailed information about 
effects on separate cue conditions, and more importantly, to test if invalid cues specifically 
impaired when MCI and APOEε4 interacted. 
The next follow-up analysis aimed to get more information about the contrast effect of 
attentional orienting. The Total Cue Validity Effect (Invalid Cue ÷ Valid Cue) was calculated 
to give information about the overall orienting function in visual attention, i.e. how effective a 
person engages, disengages and moves from one location to another (Posner & Petersen, 
1990). The Total Cue Validity Effect holds information about both the RT cost of an invalid 
cue, and the RT benefit of a valid cue. However, since both people with mild dementia, and 
APOEε4 carriers are believed to have problems reorienting attention following an invalid cue, 
but not in engaging attention after a valid cue (Greenwood, Lambert, et al., 2005; 
Parasuraman, et al., 1992), it is common to calculated further contrast effects for the Cost 
(Invalid Cue ÷ Neutral Cue) and the Benefit (Neutral Cue ÷ Valid Cue) separately. Also, the 
Alertness Effect (No Cue ÷ Neutral Cue) was calculated separately as this effect may 
distinguish if age, genotype or MCI related changes in Cost or Benefit effect are due to actual 
changes in Cost or Benefit or a byproduct of changes in Alertness (Festa-Martino, et al., 
2004).  
A third follow-up analysis for normal age groups was conducted. This analysis 
excluded the MCI group and splitted age group into three levels (Young Age (YA): 18 – 34.4, 
N = 220, Middle Age (MA): 39.8 – 60.5 years, N = 236, Old Age (OA): 60.51 – 79 years, N = 
221). The exclusion of the MCI group, and submitting normal age group factor in an omnibus 
ANOVA with the same within-subject factors and APOE, was rationalized to give more 
specific information about normal aging effects on visuospatial attention, and how normal 
aging is modulated by APOE-genotype, so we could compare these interactions with the 
predicted non-additive effect of MCI+ε4 on invalid trials.  
Because we had more men than women in our groups (male = 492, female = 244), we 
did follow up analysis for Accuracy and RT omnibus ANOVA with gender as a covariate 
(ANCOVA), to check if the observed effects developed differently when controlling for 
gender distribution. 
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3.3 Results 
Accuracy. Mean accuracy rates were generally high, ranging from 97.02% to 
98.05%. A main effect of Group was found, F(2,730) = 44.98, p < .0005, η²p = .110, being 
lowest in the MCI group (.945) and highest in the OC group (.984), and YC having an 
intermediate value (.973). A main effect of Cue Validity, F(3,2190) = 7.666, p < .0005, η²p =  
.010, was also revealed, being highest for the valid condition (.97) and lowest for invalid 
condition (.963).  No main effect of SOA was indicated, but the effect of Cue Validity 
interacted with SOA, F(3,2190) = 3.105, p = .028, η²p = .004, longer SOA was associated 
with higher accuracy for valid cues, but lower accuracy for neutral and no cues.  
The effect of Cue Validity was also modulated by APOE as indicated by the Cue 
Validity × APOE interaction, F(3,2190) = 3.51, p = .019, η²p = .005. On average non-carriers 
showed greater accuracy than ε4-carriers. APOE was further involved in an interaction with 
SOA, F(1,730) = 4.35, p = .037, η²p = .006, and in the three-way interaction Cue Validity × 
SOA × APOE, F(3,2190) = 3.25, p = .023, η²p = .004. ε4-carriers differed from non-carriers 
on invalid cues response after long SOA. As can be seen in figure 2.1a & b, APOEε4 carriers 
had more correct responses than non-carriers on invalid 2000-SOA condition. However, the 
differences were very small (from .959 to .967). Group did not modulate any of the within-
subject effects. 
Figure 2.1a & b SOA × Cue × APOE interaction on Accuracy
 
Reaction time. A main effect of Group, F(2,733) = 246.5, p < .0005, η²p = .402, 
showed that the MCI-group had in general the slowest RT (M = 837.8ms), YC displaying the 
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fastest (M = 539.6ms), and OC having a value between the two former groups (M = 674.5ms). 
The omnibus analysis showed no main effect of APOE, and no interaction between APOE and 
Group. But, the analyses revealed an expected main effect of Cue Validity, F(3,2199) = 
297.54, p < .0005, η²p =.289. The no-cue condition and invalid were associated with longest 
RT (M = 700.4ms and M = 697.5ms respectively), the valid cue with the fastest RT (M = 
652.7ms), and neutral cue with an intermediate value (M = 685.2ms). Also as expected, the 
Cue Validity effect developed over time, as indicated by a main effect of SOA, F(1,733) = 
207.381.545, p < .0005, η²p = .221, and a significant Cue Validity × SOA interaction, 
F(3,2199) = 6.479, p < .0005, η²p = .009. The reaction time increased in general for all cue-
condition when SOA increased, but the effect of SOA was greatest for neutral cues (M = 
682.3ms for 500 SOA vs. M = 712.7ms for 2000 SOA), and smallest for valid cues (M = 
644.3ms for 500 SOA vs. M = 661ms for 2000 SOA). 
A two way interaction showed that the effect of Cue Validity was modulated by 
Group, F(6,733) = 16.145, p < .0005, η²p = .042, generally because the difference between 
valid and invalid cues were smaller in the YC group than OC and MCI group. Group also 
interacted with SOA, F(2,733) = 8.181, p < .0005, η²p = .022. SOA effect was largest in the 
YC group as they increased 21.9ms due to SOA increase (M = 528.6ms for 500 SOA vs. M = 
550.6ms for 2000 SOA), OC increased 30.8ms due to SOA increase (M = 659.1ms for 500 
SOA vs. M = 689.8ms for 2000 SOA) and MCI increased 17.5ms due to SOA increase (M = 
829ms for 500 SOA vs. M = 846.6ms for 2000 SOA). 
Group was also involved in a three-way interaction with Cue Validity and SOA, 
F(6.2199) = 2.988, p = .007, η²p = .008. Generally the increase of SOA increased RT for all 
groups, with some exceptions. The increase of SOA changed contrast effect of invalid over no 
cue primarily for the YC group, but not for OC and MCI-group, thus indicating a pattern of 
response that is specific for people in young age. 
APOE-genotype also modulated the effect of the within-subject factors, as indicated in 
the three-way interaction Cue Validity × SOA × APOE, F(3,2199) = 4.771, p = .003, η²p = 
.006. Generally, non-carriers were faster than ε4-carriers in all 500 SOA conditions and in 
some 2000 SOA conditions (invalid, valid), but the mean differences were small (M = 665.1 
vs. M = 657.02 for valid, M = 704.16 vs. M = 721.34 for invalid). APOE was also involved in 
the four-way interaction Cue Validity × SOA × Group × APOE, F(6,2199) = 4.255, p < .0005, 
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η²p =.011. The significant four-way interaction in the omnibus ANOVA justified separate 
analysis for RT on invalid and valid trials. 
Separate Cue condition follow-up analysis. Invalid RT. The RT following an 
invalid cue increased when SOA increased, F(1,733) = 120.72, p < .0005, η²p = .141, but this 
effect of SOA was modulated by APOE, F(1,733) = 4.76, p = .029, η²p = .006. This effect in 
turn interacted with Group, leading to a three-way interaction, F(2,733) = 4.79, p = .009, η²p = 
.013. A closer look at this interaction showed that RT for invalid cues in the 500-SOA 
condition increased with age and due to MCI, but not due to APOE variations. The APOE 
modulation could be observed in the invalid 2000-SOA condition, which showed that the 
MCI+ε4 group exhibited a longer RT than MCI÷ε4 group (see figure 2.2).  
Figure 2.2 SOA × Group × APOE interaction for invalid RTs 
 
Valid RT. For RT following valid cues, main effects of SOA, F(1,733) = 112.93, p < 
.0005, η²p = .134, Group, F(2,733) = 232.55, p < .0005, η²p = .388, and an interaction between 
SOA and Group was revealed, F(2,733) = 14.68, p < .0005, η²p = .039. When SOA increased, 
mean RT increased for YC and OC, but RT increase due to SOA increase was less eminent in 
the MCI-group. This indicated that when people in the MCI-group engaged and focused their 
attention following a valid cue, they stayed focused, and RT did not alter due to prolonged 
SOA (see figure 2.3 for comparing group difference in attentional engagement). No 
involvement of APOE was found for RT following a valid cue.  
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Figure 2.3 SOA × Group interaction for valid RTs 
 
No cue RT. When no cue were given before target, RT varied according to Group, as 
eminent in a main effect, F(2,733) = 234.02, p < .0005, η²p  = .39, and leading to a steady 
increase in RT between the groups. YC the shortest RT (M= 550.5), MCI group had the 
slowest RT (M= 857.9), and OC the in between value (M= 692.9). A main effect of SOA, 
F(1,733) = 69.31, p < .0005, η²p = .086, and an interaction between SOA and Group, (2,733) 
= 5.89, p = .003, η²p = .016, indicated that a prolonged time of onset without a cue was 
associated with increase in RT for all groups, but the increase was smallest in the MCI group. 
Also, the two-way interaction SOA × APOE was marginal significance, F(2,733) = 3.65, p = 
.057, η²p = .005, and the three way interaction SOA × Group × APOE was significant, 
F(2,733) = 3.02, p =.05, η²p = .008. In general it appears that ε4-carriers have some longer RT 
(M=694.8) than non-carriers  (M=681.7) when SOA is short, but under a long SOA condition, 
ε4-carriers and non-carriers  RT score is about the same (M=713.5 and M=711.62 
respectively). In the three way interaction a short SOA is associated with prolonged RT for all 
ε4-carriers, but the difference between RT after a short SOA compared with RT after a long 
SOA was most eminent in the MCI group. Thus when no top down information is given about 
where the next target is presented, APOE-genotype specifically modulates performance in the 
MCI group.  
Neutral RT. A main effect of Group after neutral cues, F(2,733) = 240.29, p < .0005, 
η²p = .396 showed that the MCI group had the slowest RT (M= 844.1), the YC the shortest 
(M= 539.7) and the OC the in between value (M= 671.8). Also, a main effect of SOA 
F(1,733) = 71.408, p < .0005, η²p = .089, and an interaction between SOA × Group F(2,733) 
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= 5.73, p = .003, η²p = .015 were found, indicating that long SOA increased RT for all groups, 
but slightly more so in the OC group. No main effects or modulations of APOE found.  
Derived measures of the contrast effects. The modulation of APOE, age and 
MCI were further investigated by separate analysis in form of derived measure of the already 
mentioned contrast effects. ANOVAs for all four effects were conducted with Group and 
APOE as between subject factors, and SOA as within-subject factor. 
Total Validity Effect. A main effect of Group, F(2,733) = 36.426, p < .0005, η²p = .09 
was found for the Total Cue Validity. As can be seen in figure 2.4, the Total Validity Effect 
increased with age, but not in the MCI-group, showing that a MCI diagnose did not modulate 
the overall orienting of attention. This pattern was the same for all cue target onset intervals. 
The effect of SOA became eminent in a main effect, F(1,733) = 21.59, p < .0005, η²p  = .029, 
indicating that the Total Validity Effect increased with target time onset increase, 
independently of Group. 
Figure 2.4 Main effect Group on Total Validity Effect 
 
The SOA-effect was however modulated by APOE, F(1,733) = 4.848, p = .028, η²p = 
.007, revealing that the Total Validity Effect was higher for non-carriers  compared to ε4-
carriers in the 500-SOA condition, but the opposite pattern emerged in the 2000-SOA 
condition. In the 2000-SOA condition ε4-carriers had a greater Total Validity Effect than non-
carriers . Thus, APOE modulated the overall measurement of attentional orienting, but the 
modulation developed differently on different cue target onset conditions. The APOE 
modulation was further affected by Group, leading to the three-way interaction SOA × Group 
× APOE, F(2,733)= 5.59, p =. 004, η²p = .015. In this interaction, the modulation of APOE 
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could best be observed in the MCI-group, as MCI÷ε4 had almost the same validity effect for 
both SOA, while MCI+ε4 clearly showed a significant increase of the Total Validity Effect 
due to SOA (see figure 2.5). A two-tailed t-test of this difference revealed that it was of 
marginal significance, t(61) = -1.874, p = .066.  
Figure 2.5 SOA × Group × APOE interaction on Total Validity Effect
 
Healthy age analysis. A follow up analysis for healthy age groups was conducted for 
Total Validity Effect. An increase with age was found, as indicated by a main effect of Age 
Group, F(2,671) = 33.03, p < .0005, η²p = .090. YA had the lowest Total Validity Effect 
(28.6), OA longest (53.6) and MA having an intermediate value (47.5), see figure 2.6. Longer 
cue target intervals increased the Total Validity Effect in general, as indicated by a main 
effect of SOA, F(1,671) = 17.33, p < .0005, η²p = .025, but SOA and Age Group did not 
interact. APOE did not modulate any effects in this analysis, again indicating that the APOE-
effect is specific for the MCI group.  
Figure 2.6 Main effect Age Group                     
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Alertness Effect. A main effect of Group was found for the Alertness Effect, F(2,733) 
= 5.56, p = .004, η²p = .015, but this effect distributed itself in a somehow unexpected manner, 
being highest for OC (M = 21.1), lowest for YC (M = 10.7) and in between the two former for 
the MCI-group (M = 13.8). The effect of Group developed over time, as indicated by the 
interaction SOA × Group, F(2,733) = 4.48, p = .012, η²p = .012. YC had a smaller Alertness 
Effect after a short SOA, and a longer Alertness Effect after a long SOA, while the MCI-
group displayed the reversed pattern. OC had similar Alertness Effect for both SOAs. No 
effects of APOE were found, and a follow-up analysis with healthy age groups found a main 
effect of SOA, F(1,671) = 4.43 p = .036, η²p = .007, but failed to find any effects of age or 
APOE. 
Cost effect. To get a closer understanding of the impairment of attentional shifting due 
to a invalid target cue, a separate analysis for the Cost Effect of invalid cues, compared with 
RT for neutral cues was conducted. A main effect of Group was found, F(2,733) = 9.55, p < 
.0005, η²p = .025. Cost increases with age, but declined in the MCI-group (see figure 2.7 for 
Cost and Benefit Effects).  
Figure 2.7 Main effect Group on Cost and Benefit 
 
An increase of Cost due to genotype was also observed, indicated by a main effect of 
APOE, F(1,733) = 4.96, p = .026, η²p = .007. ε4-carriers showed a greater Cost Effect than 
non-carrier (M = 16.5ms, SD = 2.9 vs. M = 8.14ms, SD = 2.3). Cost also increased with SOA, 
F(1,733) = 7.27, p = .007, η²p = .01, and SOA was involved with APOE in a two-way 
interaction, F(1,733) = 7.19, p = .007, η²p = .01, showing that an increase of SOA clearly 
affected the Cost Effect in the ε4-carrier group (see figure 2.8).  
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Figure 2.8 SOA × APOE interaction on Cost 
 
This interaction was further modulated by Group, indicating that the rise of Cost 
Effect could best be observed in the three-way interaction SOA × Group × APOE, F(2,733) = 
3.78, p = .023, η²p = .01. The overall pattern of Cost increase with age and decline in the 
MCI-group was replicated in the 500-SOA condition. More interestingly, in the 2000-SOA 
condition the MCI-group splitted according to their genotype. In the 2000-SOA condition 
MCI÷ε4 demonstrated the same decline as in the 500-SOA condition, but for the MCI+ε4 
Cost Effect continued to rise. Mean RT cost was -8.1ms for MCI÷ε4 group, and 37.9ms for 
MCI+ε4 group in the 2000-SOA condition (see figure 2.9a & 2.9b).  
Figure 2.9a & b. SOA × Group × APOE interaction on Cost 
 
A two-tailed t-tests for this effect revealed that the difference between MCI+ε4 group 
and MCI÷ε4 group reached a level of significant, t(61) = -2.313, p = .024. Thus, as with the 
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separate effect of invalid cues, and the Total Validity Effect, the MCI+ε4 group distinguished 
itself from the MCI÷ε4 group in the 2000-SOA condition also when Cost Effect was 
measured. APOE was specific involved in modulating the effect of MCI after long SOA.  
Healthy age analysis. Follow up ANOVA with healthy control group only indicated 
that the Cost Effect increased with age and stabilized after a certain level, as evident in a main 
effect of Age Group, F(2,671) = 8.15, p < .0005, η²p = .024 (see figure 2.10 for Cost and 
Benefit Effect for healthy age groups). Effects of SOA and APOE were not significant in this 
analysis.  
Figure 2.10 Main effect of Age Group on Cost and Benefit 
 
Benefit Effect. A main effect of Group was found for the Benefit Effect, F(2,733) = 
21.97, p < .0005, η²p = .057. As can be seen in figure 2.7, the Benefit Effect increased with 
age and in the MCI group. A marginal main effect of APOE was also revealed, F(1,733) = 
3.81, p=.051, η²p = .005, and a two-way interaction between Group and APOE, F(2,733) = 
4.11, p = .017, η²p = .011. As can be seen in figure 2.11, the MCI-ε4-non-carriers had a 
greater increase in Benefit than the MCI-ε4-carriers. Thus, the MCI+ε4 group had lower 
Benefit Effect compared to the MCI÷ε4 group, indicating that combination of MCI and 
genetic risk factor contributed to a decline in the top down advantage of a valid cue to engage 
attention quickly. However, a two-tailed t-test failed to show that the difference between the 
MCI+ε4 and MCI÷ε4 was of significance (p = .115). 
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Figure 2.11 Group × APOE interaction on Benefit
 
Healthy age analysis. A further analysis for normal age groups without the MCI group 
showed the same pattern of steady increase of Benefit Effect due to age (figure 2.10), as 
indicated by a significant main effect of Age Group, F(2,671) = 14.82, p < .0005, η²p = .042. 
The Benefit Effect also increased when SOA increased, F(1,671) = 6.78, p = .009, η²p = .01, 
but SOA did not modulate the effect of age, and APOE did not modulate any effects in this 
analysis. Overall, the Benefit Effect was characterized by an overall increase in the normal 
aging groups, as well as in the MCI-group. 
Gender covariate follow up. On omnibus ANCOVA measuring accuracy response, 
gender covariate was not involved (p’s > .243). However, on omnibus ANCOVA measuring 
RT, gender interacted with SOA, F(1,732) = 11.399, p = .001, η²p = .015, as RT for men 
increased more due to SOA increase than RT for women. Gender did alter general effect size 
on response pattern in some way, as for instance partial eta squared in two-way SOA × Group 
ANOVA was .022, compared to .035 in the current ANCOVA.  
3.4 Discussion 
Consistent with previous results, the omnibus ANOVAs showed that endogenous top 
down information (Cue Validity) about target location affected the accuracy and reaction time 
responses in covert shifting of visuospatial attention in all groups. Main effects of Group on 
different measures revealed that normal aging was associated with a decline in accuracy 
response rate and increase in reaction time, and MCI was associated with further impairment, 
in a way that might be interpreted as additive. With respect to APOE modulations, our results 
did not replicate previous results showing that healthy ε4-carriers are associated with decline 
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in visual attention (Greenwood, Lambert, et al., 2005; Greenwood, et al., 2000; Parasuraman, 
Greenwood, Kumar, & Fossella, 2005). In general we found no modulations by APOE in any 
of the healthy age group analysis, only in interaction with MCI.  
With respect to the effects of SOA, previous studies have indicate that a long SOA 
may reduced inhibition ability in dementia patients (Parasuraman, et al., 1992). Greenwood, 
Parasuraman and Haxby (1993) have also shown that age effects are best found on longer 
SOAs. Indications were found that long SOA impaired the ability for visual reorienting for 
both normal aging and MCI aging processes in generally. The most interesting results were 
however revealed when Group, APOE and SOA interacted on measures of invalid RTs 
showing that long SOA was associated with largest RT increase in the MCI+ε4 group 
following an invalid cue.  
We predicted to find a non-additive effect of MCI on measures that activate the 
attentional reorienting system, especially when APOE was involved as a modulating factor. 
Evidence supporting this prediction were found on several levels of analysis involving an 
invalid cue. On univariate measures of invalid RTs, and on ANOVA measures of Total 
Validity Effect and Cost Effect it was found that MCI+ε4 showed longer RT than MCI÷ε4, 
mainly after a long SOA. The effect was interpreted non-additive, because response pattern in 
the MCI+ε4 group were different than healthy age-matched control and MCI÷ε4 group.  
The contrast effects Cost and Total Validity are generally believed to reflect measure 
of visuospatial reorienting, and captures how efficient someone’s ability disengage, and move 
one’s attention from on target location to another (Festa-Martino, et al., 2004). On healthy 
aging analysis, we found steady increase on the Total Validity Effect. When MCI group was 
submitted in an ANOVA as one factor, performance was the same as age-matched healthy 
control participants’, thus indicating no effect of MCI on Total Validity measures. A non-
additive response pattern on Total Validity measures became only eminent when MCI was 
stratified according to APOE genotype. A combination of MCI diagnosis and being carriers of 
AD-risk allele, resulted in specific RT impairments on long SOA trials. The MCI+ε4 had 
greater Total Validity Effect after longer SOAs compared to MCI÷ε4. As no APOE 
modulation were revealed in any normal aging processes, this indicated that APOE served as 
a factor that specifically affected pathological aging processes, giving rise to this differences 
between normal aging decline and MCI-aging decline. This is consistent with general believes 
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that APOE increases risk for AD-development (Wang, et al., 2010), and affects cognitive 
performance in MCI and AD-groups more than in healthy control groups (Smith et al., 1998).  
With respect to the Cost Effect, we found results that most clearly indicated a non-
additive effect of MCI+ε4. The Cost Effect has been shown to be sensitive to dementia and 
APOE modulations (Greenwood, Lambert, et al., 2005; Parasuraman, et al., 1992). Cost 
Effect is believed to develop steady across normal age (Greenwood, et al., 1993), but patients 
with mild AD are believed to have greater Cost Effect than healthy controls (Parasuraman, et 
al., 1992; Parasuraman, et al., 2002; Posner, et al., 1984). More importantly, previous studies 
have indicated that measures of Cost Effect are sensitive to dementia disease, and that effects 
of normal aging are qualitatively different from effects of dementia (Greenwood, et al., 1993), 
an important step for detecting prodromal AD-development. In our study we found evidence 
for a non-additive effect of AD high risk group (MCI+ε4). A non-additive dysfunction in the 
attentional system in early AD patients is also consistent with metabolic abnormalities in the 
parietal lobe which are correlated with AD (Parasuraman, et al., 2002), and neuroimaging 
studies that indicate that abnormalities in the integrity in the parietal lobe are associated with 
Cost Effect measures (Parasuraman & Haxby, 1993; Posner, et al., 1984). We found that the 
Cost Effect increased with age, but only up to a certain level, after which it plateaued. A 
combination of MCI and APOEε4 contributed to an vast increase of Cost RT (see figure 
2.9b). This increase was completely different from the stabilization of response pattern found 
in healthy age-matched control, and MCI÷ε4 group. Together these finding may indicate that 
people with high risk for AD-development (MCI+ε4) show a qualitatively different pattern 
compared to normal age-matched controls in different measures that involved an invalid cue, 
consistent with our prediction that only measures sensitive to the attentional reorienting 
system will detect such a difference of possible prodromal AD-development.  
On measures after valid cues we predicted to find additive effects of MCI, because 
only conditions activating the attentional reorienting system were predicted to lead to non-
additive effects of MCI and APOE. A valid cue is frequent and will therefore not activate the 
attentional system. Top-down orienting towards goal relevant objects like a valid cue are 
expected to activate the dorsal frontoparietal network (Corbetta, et al., 2008), but not the 
ventral. Previous study have found that people with dementia can use such top-down 
information effectively (Parasuraman, et al., 1992). We found a steady RT increase due to age 
and MCI on separate univariate measures of valid RTs, consistent with our predictions of an 
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additive effect of MCI on attentional engagement. We did not find interaction effects of MCI 
and APOE on separate valid cues trials. However, some indications were given that the 
MCI+ε4 group showed response pattern that was different from MCI÷ε4 and age-matched 
control when the Benefit Effect was calculated. This observed pattern indicated that MCI÷ε4 
responded more similar to OC, and different from the MCI+ε4 group. As these response 
pattern may indicate a non-additive effect of MCI and APOEε4 on measures of top-down 
benefit from valid cues as well. This would be in conflict with our prediction, because a valid 
cue is not believed to activate the attentional reorienting system. A follow up t-test indicated 
however that the MCI group did not differ significantly due to APOE stratification.  
On measures of the phasic Alertness Effect, no modulations of APOE were found, and 
the separate neutral cue analysis indicated a stable pattern of increase for all groups. These 
findings have two important implications: first, it indicates that MCI+ε4 did not show specific 
effects on alertness measures of attention, and second, it indicated that changes in the neutral 
cue could not explain the different response pattern observed in Cost. Phasic alerting is 
elicited by the presence of a cue, in a sense that they give information about that a target will 
appear soon, and it is believed that the alerting aspect of attention is mediated by ascending 
noradrenergic projection system originating within the locus coeruleus (Festa-Martino, et al., 
2004). Since the Alertness Effect is not specifically modulated by MCI and APOEε4, we may 
conclude that only an invalid cue trials were sensitive enough to capture early impairments 
associated with the high AD-risk group. 
In sum, we found indication consistent with our predictions. The response patterns in 
the MCI+ε4 on invalid trials seemed to be non-additive in comparison to normal aging 
effects. Other measures of attention did not show this effect, indicating that this non-additive 
effect of MCI and APOEε4 was specific for the attentional reorienting system. 
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4 Experiment 2: Continuous Working 
Memory Updating 
4.1 Background and Predictions 
This experiment include different measures of executive working memory, and a non-
additive effects of MCI and APOEε4 is predict only on measures that are believed to activate 
the attentional reorienting system (i.e. on BX-trials). The following section will introduce the 
experiment, and based on previous findings, general predictions about effects of normal 
aging, MCI and APOE will be given. At the end of this section it will be turned to how one 
may argue that BX-trials are similar to invalid arrow cues in experiment 1, and thus probably 
will elicit the attentional reorienting system. 
This experiment is often referred to as the AX-CPT task and is believed to measures 
context processing/updating capacity (Braver & Barch, 2002; Braver, et al., 2005), i.e. the 
ability to represent the goal of a task while processing and responding to a stream of 
information (Braver, et al., 2005). To perform a task, a person has to remember the context 
representation, or rule. The AX-CPT task requires the participant to make a target response to 
X, only when it follows an A (Braver, et al., 2005). Thus, for each trial (AX, AY, BX, BY) 
participants have to keep context information activated to give the correct behavioral 
response. A context representation like that will bias processing in task performance (Braver 
& Barch, 2002), as information about what to do when a target appears will make a person 
predict upcoming cues. The ability to keep this representation of context information 
activated on-line is important in high load working memory situations where there is a strong 
competition of response selection, and especially when the appropriate response is infrequent 
(Braver, et al., 2005). Thus, a person has to know which cues are relevant for the behavior 
context information expects him/her to perform, i.e. to respond to X after A. This may be seen 
as quiet a demanding task, and it is shown that measures on this task are sensitive to normal 
age-related decline (Braver & Barch, 2002), AD-related decline(Braver, et al., 2005), and 
modulations of APOE (Reinvang, Winjevoll, et al., 2010). The current experiment is similar 
to experiment 1, as it involves manipulations of cue validity. Both valid and invalid cues are 
presented, and since different effects of MCI and APOE were found on invalid vs. valid cues 
in experiment 1, we expect to find similar patterns also in this experiment. 
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With respect to valid cues, no specific effects of MCI and APOE are expected. The 
function of letter A in AX trials can be seen as similar to a valid arrow cue in experiment 1. 
The AX target trial occurs with high frequency in the task (70%) and will leads the 
participants attention to a particular response bias (i.e. to expect the letter X). The difference 
is that a valid arrow cue will lead attention in a visuospatial direction, while the letter A will 
lead attention to a internally set of context rule. Thus, an AX-trial, like a valid arrow will 
probably elicit top-down orienting towards goal relevant objects, a function expected to 
activate the dorsal frontoparietal network (Corbetta, et al., 2008). As previous studies have 
not reported specific deficit due to age or mild dementia in engagement of attention after a 
valid cue (Parasuraman, et al., 1992), it is therefore not expected that normal aging and MCI 
effect measures on AX trials besides general slowing.  
With respect to how general aging processes affect different AX-CPT measures, it is 
commonly believed that the AX-CPT task is able to distinguish different cognitive strategies 
in aging (Braver, et al., 2001; Braver, Gray, & Burgess, 2007). Braver et al. (2007) 
distinguished between proactive and reactive strategies. Proactive strategies are implemented 
in participants with sufficient motivation and/or context updating capacity, as they may tend 
to “predict” the upcoming stimulus, whereas reactive strategies are believed to be 
implemented in people with less motivation or capacity (Braver, et al., 2007). When using a 
reactive strategy, people may wait for the target letter X to appear and then try to remember 
the identity of the previous letter, so they can determine if the X is a target or not (Braver, et 
al., 2007). Proactive strategies are believed to be mediated by lateral areas of the PFC and DA 
midbrain systems, while reactive strategies are believed to be mediated by neural substrates in 
the anterior cingulate cortex, lateral prefrontal cortex, medial temporal cortex and others 
(Braver, et al., 2007). In context of this study, it will be predicted that the YC group show a 
pattern indicating a proactive strategy, while MCI group will show a reactive strategy 
response pattern.  
The response pattern believed to reflect a proactive strategy is: better response patterns 
on BX trial then on AY trials (Braver, et al., 2005). Increased RT in AY, but decrease in BX 
trial in young people may reflect an proactive strategy, because when the letter A appears as a 
cue, young people will expect a X, but as a non-X target appears, they will have to inhibit the 
expected response pattern. However, when a non-A (B) cue appears, they will exclude target 
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X, and thus a X after B will not make them activate reactive strategies. Together, one may 
expect higher RTs after AY compared to RTs after BX in the young control group. 
If we assume people with MCI to use more reactive strategies, then one may expect 
them to have impairments in BX trials as well as AY trials, because a reactive strategy usage 
in not believed to activate proactive predictions when a B cue appears. Thus, the letter X after 
B will make people who use the reactive strategy, and thus one may expect specific RT 
increase in BX-trials. Together, we expect the MCI group to use more reactive strategies than 
young control group, since they generally are believed to be cognitively more impaired. It will 
be explored whether APOE may modulate the usage of strategy, since the MCI+ε4 in 
experiment 1 have shown to have more impairments than MCI÷ε4 group. 
When calculating proactive/reactive strategy usage, the BX-trial is important because 
of it’s relation to AY-trials. However, this current study is mainly interested in isolated BX-
trials response patterns, because it is argued that BX-trials will elicit underpinnings of the 
attentional reorienting system. Again, like the invalid arrow condition in experiment 1, a BX-
trial is believed to activate the attentional reorienting system because expectations are 
violated, and the target is behaviorally relevant (Espeseth, et al., in press). According to the 
criteria of unexpectedness, both AY-trials and BX-trials are relatively rare, and involve 
invalid cues that violates expectations. In fact, previous studies have found that an AY-trial is 
associated with age-related impairments on both accuracy and reaction time measures 
(Braver, et al., 2005). However, the Y in AY is not behaviorally relevant, and thus not 
believed to elicit the attentional reorienting system. Therefore we do not expect specific 
effects of MCI and APOE on AY trials. 
The X in the BX trials on the other hand, is unexpected and behaviorally relevant since 
it is identical to the AX target, hence expected to activate the ventral frontoparietal system to 
be together with the dorsal system (Corbetta, et al., 2008). RT measures after a BX trials are 
conceptually similar to invalid arrow cues in the visuospatial attention task, as both measure 
aspects of the attentional reorienting system, although through different modalities. The 
question is whether we can expect to find non-additive effects of MCI and APOEε4 on BX 
trials. As mentioned, Braver et al. (2005) found an steady decline due to age and AD-related 
pathology on BX-trials consistent with the viewpoint that mild dementia is an additive 
acceleration of normal aging processes (Braver, et al., 2005). Thus, we expect to find an 
additive decline of age and MCI when the MCI groups is analyzed as one group. However, 
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Braver et al. (2005) did not involve genetic factors in their study. It was pointed out that 
because their study was cross-sectional and not longitudinal, they could not rule out cohort 
effects (Braver, et al., 2005). Others have also argued that there exists deficits in people with 
early dementia that are qualitative different compared to cognitive deficits associated with 
normal aging, and these differences are important for prodromal dementia detection (Morris 
& Price, 2001; Parasuraman, et al., 2002). Since we found specific APOE modulations for the 
MCI group in visuospatial attentional reorienting, we expect to find specific interactions 
between APOE and MCI on BX-trials. The findings in experiment 1 indicated a non-additive 
effect of the MCI+ε4 group on cost of invalid arrow cues, thus we expect to find a similar 
qualitative difference between MCI+ε4 and age-matched control group on BX trials. 
4.2 Method 
4.2.1 Stimuli and Procedure 
Red colored capital letters were presented  one at a time in a continuous series on a 
black computer screen (1° × 1.2°  of visual angle, font: Arial). A trial was defined as a pair of 
letters. Targets were defined as the letter X preceded by the letter A (AX trials). All other 
letters were considered distracters. AX-target frequency was 70%, thus, the first letter could 
be taken to be a probability cue for the second. Non-target trials were divided equally between 
AY, BX, and BY trials (10% each). B and Y in this context mean any other letter than A or X. 
Stimuli were presented on an EIZO 21-in. CRT monitor, and the experimental paradigm was 
controlled and responses collected by the E-Prime software (Schneider, et al., 2002). 
Participants were asked to respond by key presses on an E-Prime compatible response box for 
every letter presented on the screen. Each letter was presented for 300 ms, and the stimulus 
onset asynchrony (SOA) was 2000ms. Participants were instructed that correct non-target 
stimuli response should be given by pressing the left-most key on the response box with the 
left index finger, and target stimuli (X after A) by pressing the right-most key with the right 
index finger. Participants were first given a white sheet of paper where a line of red letters 
was presented, and instructed to practice responses manually by writing either the letter V 
(initial letter for the Norwegian word venstre, meaning left) or H (initial letter for the 
Norwegian word høyre, meaning right) under presented letter. After this manual practice, a 
practice block on the computer, consisting of 20 trials (40 trials for the patient cohort) was 
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implemented. The test then contained 6 blocks of 50 trials. All stimuli had to be responded to, 
but only responses in the time window 100–1500ms after stimulus onset were included in the 
analysis. The remaining 500ms period before the next stimulus onset was used for auditory 
feedback where errors were indicated. Participants were instructed that a short beep would 
occur if they respond inaccurate to keep them concentrated. The experiment lasted 20-30 
minutes.  
4.2.2 Participants and Genotyping 
300 participants in the healthy control group aged 22-77 (M = 54, SD = 14.7), and 57 
MCI patients aged 46-77 (M = 60.2, SD = 6.8) conducted this experiment. For recruitment, 
screening, genotyping and exclusion procedures see study 1. 
4.2.3 Statistical Analysis 
First we conducted a repeated-measure ANOVA on Accuracy response rate for all 
conditions. Condition (AX, AY, BX, BY) was submitted as within-subject factor, and Group 
(YC  (22 - 45.4 years, N = 87), OC (45.5 – 76.7 years, N = 212), MCI (46 - 77 years, N = 55)) 
and APOE (ε4-carrier, N = 128, ε4-non-carrier, N = 226) as between-subject factors, leaving 
six groups: YC+ε4, N=29, YC÷ε4, N=58, OC+ε4, N=78, OC÷ε4, N=134, MCI+ε4, N=21, 
MCI÷ε4, N=34. The second omnibus ANOVA was conducted with the same variables, but 
mean of median RTs were calculated for each condition. Also, separate analysis for each 
condition were submitted in univariate ANOVAs, to get results of possible simple effects of 
Group and/or APOE on specific Conditions. 
The next follow up analysis aimed to get a more detailed understanding of normal 
aging effects on different conditions, and how this may be similar/different from the effect of 
MCI. For this analysis we excluded the MCI group, and subdivided healthy participants in 
three groups: Young Age (YA): 22 - 48.7 years, N = 100, Middle Aged (MA):  48.8 – 63.6 
years, N = 1000 Old Age (OA): 63.65 – 76.77, N = 99. ANOVAs on overall Accuracy rate, 
mean of median RTs, and RTs for each condition were submitted in this follow up analysis, 
with Condition (4) as within-subject factor, and Age Group (3) and APOE (ε4-carrier, N = 
192, non-carrier, N = 107) as between-subject factor.  
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In the third follow up analysis we wanted to get a clearer picture for between-group 
effects on Conditions of interest for attentional reorienting (BX and AY). We controlled for 
effects of baseline (AX), by calculating the proportional effect of each groups RT on 
respectively AY, BX, BY. This was done by calculating three Condition within-subject 
factors 1:AYprop (AX-AY/AX), 2: BXprop (AX-BX/AX), 3:BYprop (AX-BY/AX). Group 
(3) and APOE (2) were submitted as between-subject factors.  
Also in this experiment we did a follow up analysis for all omnibus ANOVAs with 
gender as a covariate (ANCOVA) (male = 228, female = 126), to check if the observed effects 
developed differently due to gender. 
4.3 Results 
Accuracy. As expected, there was a significant main effect of Condition, F(3, 1044) 
= 189.5, p < .0005, η²p = 0.35, due to lower accuracy in AY (85%) and BX (92%) trials, than 
in AX (96%) and BY (99%) trials (see Figure 3.1). There were no other significant main 
effects or interaction effects in this ANOVA (p’s > 0.1). However, there was a marginal effect 
of Group on BX accuracy in a univariate effects follow up analysis, F(2,348) = 2.71, p = .068, 
η²p = .015, indicating that YC had highest accuracy (M = .936), MCI the lowest (.904), and 
OC intermediate score (M = .926) on BX-trials. Group also interacted with APOE on BX-
trials, F(2.348) =  3.423, p = .034, η²p = .019, indicating that MCI group had the clearest drop 
in accuracy rates due to genotype (M = .927 for ÷ε4 vs. M = .88 for +ε4). On univariate 
ANOVA for AY-trials, no significant main or interaction effects were found for. On 
univariate ANOVA for AX-trials however, a main effects of Group was found, F(2,348) = 
6.88, p = .001, η²p = .038, and similar effect for BY-trials, F(2,348) = 3.214, p = .041, η²p = 
.018, both revealing a pattern were OC had the highest accuracy, MCI the lowest, and YC the 
intermediate value. However, differences were small (e.g. difference between OC and MCI on 
BY trials were .992 vs. .982). 
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Figure 3.1 Main effect Condition on Accuracy Rates
 
Reaction time. There was a significant main effect of Condition, F(3, 1044) = 396.6, 
p < .0005, η²p = .53. RTs were longer in AY (M = 527 ms) and BX (M = 415 ms) trials than 
in AX (M = 351 ms) and BY (M = 363 ms) trials. There were also significant main effects of 
APOE, F(1, 348) = 4.3, p = .039, η²p = .012, were ε4-carriers were slower than non-carriers  
(M = 402.97 vs. M = 424.82). Also, a main effect of Group, F(2, 348) = 61.0, p < .0005, η²p = 
.26. showed that YC were faster than OC, and OC faster than the MCI group (M = 341.2, M 
=397.2, M = 503.3). Group and APOE interacted in a two-way interaction, F(2, 348) = 4.0, p 
= .018, η²p = .023, due to the fact that APOE only had an effect in the MCI group (see figure 
3.2). The steady increase in RT for all groups was also found in separate univaritate follow up 
analysis for AX, AY, BX and BY. For separate BX, a main effect of APOE, F(1, 348) = 
5.528, p = .019, η²p = .016, and interactions between Group and APOE, F(2, 348) = 5.688, p = 
.004, η²p = .032 were found, indicting a similar pattern: ε4-carriers were slower than non-
carriers (M = 391.5ms vs. M = 437.9ms), a difference mainly attributed to slowing in the MCI 
group (M = 476.5ms for ÷ε4 vs. M = 626.5ms for +ε4). 
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Figure 3.2 Group × APOE interaction
  
In the omnibus ANOVA, there was also a significant Condition × APOE interaction, 
F(3, 1044) = 5.0, p = .012, η²p = .014, due to longer RTs on BX and BY-trials for ε4-carriers 
(figure 3.3). There was also a significant Condition × Group interaction, F(6, 1044) = 14.6, p 
< .0005, η²p = .077, showing that the MCI group were slower than OC and YC, particularly on 
BX trials (see figure 3.4). 
Figure 3.3 Condition × APOE interaction & Figure 3.4 Condition × Group interaction 
 
Interestingly, there was a significant three-way interaction (Condition × Group × 
APOE interaction), F(6, 1044) = 4.9, p = .002, η²p = .027. Figure 3.5a and b show that MCI 
patients are overall slower than OC and YC, and OC slower than YC in all conditions for both 
ε4-carriers and non-carriers .The MCI+ε4 group clearly stands out as slow on BX-trials 
compared to MCI÷ε4 group and OC groups. 
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Figure 3.5a & b Condition × Group × APOE interaction 
 
Healthy age analysis. The follow up omnibus ANOVA with healthy age control was 
conducted to compare more detailed effects of normal aging with observed MCI effects. For 
mean accuracy data there was a large main effect of Condition, F(3, 879) = 239.9, p < .005, 
η²p = .45. No main effects of Age Group or APOE were found. However, there was also a 
Condition × Age Group interaction, F(6, 879) = 2.3, p = .031, η²p = .016, as the MA group 
had higher AY accuracy than OA and YA participants (see figure 3.6). In addition, there was 
a significant Condition × APOE interaction, F(3, 879) = 4.1, p = .026, η²p = .014. Figure 3.7 
shows that 4-carriers had lower accuracies in AY-trials, but there were no differences in the 
other three conditions. There were no further significant results in this analysis. 
Figure 3.6 Condition × Age Group interaction 
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Figure 3.7 Condition × APOE interaction 
 
For analysis on RT data in healthy control groups, there was a strong main effects of 
Condition, F(3,879) = 505.9, p < .0005, η²p = .63, and of Age Group, F(2,293) = 24.1, p < 
.0005, η²p = .14, but no main effect of APOE (p = .86), or APOE × Age Group interaction (p = 
.96) were revealed, confirming that APOE has no impact on RT performance among healthy 
controls. There was a significant Condition × Age Group interaction, F(6, 293) = 4.87, p = 
.002, η²p = .032. Figure 3.8 shows that this interaction pattern is different from the same 
interaction pattern when MCI are included (figure 3.4), as none of the healthy control groups 
showed a specific RT increase on BX-trials compared to AY-trials. On separate univariate 
follow up analysis for each trial, main effects of Age Group (p’s < .0005), but no effects of 
APOE were found for all trials. A pattern of steady RT increase due to age were found for all 
trials. On separate BX-trials RTs for groups were: YA = 306ms, SD = 14.4, MA = 372ms, SD 
= 14.4, OA = 408ms, SD = 14.3.   
Figure 3.8 Condition × Age Group interaction 
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Proportional RTs follow up. When controlling for effects of baseline (AX) on reaction 
time for AY, BX and BY, effect of between-group factors became even clearer. Main effects 
of Group, F(2,348) = 14.453, p < .0005, η²p = .077, and APOE, F(2,348) = 7.024, p = .008, 
η²p = .02 revealed a similar pattern as above. As can be seen in figure 3.9, showing two-way 
interaction Group × Condition, F(4,696) = 10.405, p < .0005, η²p = .056, effect of MCI on 
BX-trials became more distinct when controlling for baseline. Group and Condition also 
interacted with APOE in a three-way interaction, F(4,696) = 3.769, p = .014, η²p = .021, 
indicating the same pattern as above. MCI+ε4 clearly exhibited a different response pattern on 
BX-trials compared to MCI-non-carriers and OC group (figure 3.10b). 
Figure 3.9 Group × Condition interaction – proportional RTs for each group 
 
Figure 3.10a & b Condition × Group × APOE interaction - proportional RTs for each group
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Gender covariate follow up. On ANCOVA measuring accuracy response rate, gender 
was involved as a main effect, F(1,350) = 6.687, p = .01, η²p = .019, and with Condition, 
F(3,1050) = 6.029, p = .005, η²p = .017, and on omnibus ACNOVA measuring reaction time, 
gender was only involved with Condition, F(3,1050) = 6.664, p = .003, η²p = .019, indicating 
that men had more correct than women (M = .937, SD = .003 vs. M = .925, SD = .004), 
mainly due to differences in AY-trials, whereas on RT measures on the other hand, men were 
faster on all conditions except AY-trials. 
4.4 Discussion 
The results revealed an expected main effects of Condition for both accuracy and 
reaction time. There were also clear main effects of Group, YC scoring faster than OC, and 
OC faster than MCI on RT measures, and on univariate BX accuracy measures a pattern of 
decline due to age and MCI appeared. Braver et al. (2001) found that older adults were faster 
and had more correct responses than younger control on AY-trials. We did not find evidence 
for this in accuracy measures including MCI, but on accuracy measures involving only 
healthy adults, we found a curvelinear relationship between YA-MA-OA, indicating that 
middle aged controls had more correct responses than both young control, and old controls. 
According to valid cues (AX-trials), no specific effects of age and MCI besides general 
slowing were predicted. Results gave evidence for this predictions, as RTs on AX-trials 
increased steady across healthy age groups, and due to MCI, regardless of APOE possessions. 
The AX-CPT task is also believed to be able to distinguish proactive and reactive 
cognitive strategies in aging (Braver, et al., 2007). The YC group was predicted to show 
patterns indicating proactive strategies (i.e. higher RTs on AY than on BX-trials). Evidence 
was found that not only the YC group, but also the OC group used more proactive strategies, 
as healthy age follow up revealed that all age groups had higher RTs on AY than on BX-
trials. It was also predicted that people with MCI used more reactive strategies, as 
impairments in BX-trials as well as AY-trials were expected for this group. Results from 
omnibus ANOVA measuring RTs showed that MCI group had higher RTs on AY-trials than 
on BX-trials, thus contradicting the prediction and indicating that the MCI group as a whole 
used proactive strategies. However, the difference between AY and BX-trials were smaller 
compared to what was found for YC and OC groups. When stratifying the MCI group 
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according to APOE-genotype, a different pattern emerged, i.e. the MCI+ε4 group had similar 
RTs for both AY and BX-trials, indicating that this group uses more reactive strategies.  
The final prediction concerned a non-additive effect of MCI and APOE on BX-trials 
only, as the MCI+ε4 group is believed to have highest risk for AD-development (Wang, et al., 
2010), and because BX-trials are believed to activate the attentional reorienting system. 
Consistent with Braver et al. (2005) evidence was found that people most likely to develop 
AD (i.e. the  MCI+ε4 group) had longer RTs on BX compared to MCI÷ε4 and age-matched 
control (see figure 3.5b). The healthy age follow-up analyses excluding MCI patients indicate 
that this effect was not associated with normal aging, and the MCI÷4 groups response pattern 
was more additive to normal aging decline. Braver et al. (2005) concluded that their data 
indicated mild dementia process as an acceleration of normal aging processes (Braver, et al., 
2005). However, their study did not involve genetic factors. Finding from the current study 
indicate that when genetic factors are included in the analysis, one can distinguish a 
qualitatively different response pattern for the group that is most likely to develop AD on BX-
trials. 
Conflicting with our predictions, the RT omnibus ANOVA indicated that MCI+4 
group revealed non-additive pattern qualified by a likely reactive strategy usage in the 
MCI+ε4 group (i.e. same RTs for BX and AY-trials). However, as mentioned above, the main 
interest of this study was isolated BX-trials RTs. The Y in AY-trials is not behaviorally 
relevant, and thus not likely to activate the attentional reorienting system. In follow up 
analysis controlling for AX-baseline effect, the specific effect of MCI+4 on AY-trial RTs 
disappeared. In this follow up, the MCI+4 group also indicated a proactive strategy usage. 
Taken together this indicates that specific increase in BX-trial RTs seems to be more robust 
than effects on AY-trials. Also, the effect on BX-trials is limited to individuals with high risk 
for AD (MCI+4). This result is similar to what was found on Cost Effect of MCI+4 in 
experiment 1. The similarities are due to behaviorally relevant target that are was preceded by 
an invalid cue. APOE4 modulated the effect of MCI diagnosis in a way that distinguished 
this group from normal aging pattern, and from MCI÷4s performance. This is consistent with 
our predictions, as we expected to find non-additive effects of MCI and APOE4 only on 
these measures, indicating that measures of the attentional reorienting system are sensitive to 
detect possible prodromal AD-development. 
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5 Experiment 3: Visuospatial Working 
Memory 
5.1 Background and Predictions 
Evidence from both structural imaging studies and genetic studies indicate that 
changes in the frontal-stratial areas and changes in the medial temporal lobe are factors 
influencing age-related decline in executive function and memory functions (Buckner, 2004). 
The aim in with this experiment was to ask if MCI and APOE affected measures of 
visuospatial working memory differently than measures that activate the attentional 
reorienting system. It was investigated if and how normal aging processes can be 
differentiated from MCI-related aging processes on measures of visuospatial working 
memory, as previous studies have shown a decline in working memory function due to age 
and early AD (McKhann et al., 1984; Salthouse, et al., 1989). Because APOE modulations 
were found specifically for the MCI group in experiment 1 and 2, one may ask if the presence 
of an APOEε4 allele affects the performance for healthy individuals and/or people with MCI 
differently on current working memory measures as well. Previous studies have indicated that 
healthy ε4-carriers exhibited deficits in both visual and non-visual measures of working 
memory recall (Bondi, et al., 1999; Greenwood, Lambert, et al., 2005; Reinvang, Winjevoll, 
et al., 2010), so one would expect to find modulations of APOE in healthy participants, and 
even in the MCI group as this was revealed in experiment 1 & 2. However, this experiment 
does not involve infrequent and behaviorally relevant targets that may activate the attentional 
reorienting system, and according to our initial prediction, we do not expect to find specific 
non-additive effects of MCI+4 on current measures of visuospatial working memory.  
5.2 Method 
5.2.1 Stimuli and Procedure 
A spatial working memory based on Greenwood et al. (2005) was used. Stimuli were 
presented on an EIZO 21-in. CRT monitor, and an E-Prime software (Schneider, et al., 2002) 
controlled the experimental paradigm and collected responses data. After a fixation cross 
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which was presentation for 1 second on the center of the screen, one, two or three black target 
dots (.67° in diameter) appeared at random locations on the screen, and stayed for 500msec. 
After the black dots disappeared, a new fixation cross appeared in the center of the screen and 
lingered randomly for either 2.5sec, 3sec or 3.5sec. After this delay a single red dot appeared 
on the screen. This red test dot appeared either at the same location as one of the black target 
dots (match condition), or at a different location (non-match condition). Non-match condition 
varied with three levels of distance (about 2°, 4° or 8° apart from the red dot), and participants 
were asked to decide whether the test dot location matched one of the target dots. Total trials 
of 252 were distributed over 4 block, each block consisted of 63 trials and contained 23 match 
trials, 13 non-match close distance trials, 13 non-match medium distance trials, and 13 non-
match long distance trials. Participants were seated in front of the computer monitor with the 
response box between their hands. An instruction appeared on the screen, and was read out 
loud for the participant before the practice block started, consisting of 21 trials. Participants 
were asked to remember the target location/s of the black dot/dots, and compare the first 
location/s to the location of the red dot. If the red dot appeared on the same spot as one of the 
target locations, they were asked to press the leftmost key with the left index finger as fast and 
as accurate as possible. But if the red dot appeared not on the same location as one of the 
black dots, they were to press the rightmost key with the right index finger. Participants were 
notified extra for the non-match close distance condition, and told that when red and black are 
not presented in the same location, the difference between them can be quiet small (about 
1.5cm). Participants were given the opportunity for short breaks between each block. The 
whole experiment lasted roughly for 30-35 minuets. 
5.2.2 Participants and Genotyping 
A total of 364 people participated in this study. Some problems with extreme outliers 
in the accuracy response rate (below 1% in some distance conditions) called for exclusion 
action. Different cut-off criteria for exclusion were inspected. First a 50% accuracy cut-off 
rate for all distance conditions was tried, but this would leave a relatively small MCI group 
(40 out of 50). Other cut-off procedures were tested, for instance a minimum 30% correct 
response on all non match condition and 50% on match condition but this still left a small 
MCI group (N = 44). Another cut-off procedures was to exclude all who had less than 1 
correct response on all non-match and load conditions, and 50% correct accuracy rate on 
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match condition, but this would still leave out 10% of the MCI group (N=45). In the end it 
was concluded that no good cut-off criteria can be met without loosing important information 
about the MCI group. Thus, a 50% accuracy response rate cut-off for all load condition on 
match trials was admitted, thereby excluding 2 participants in the young control group, 4 in 
the old control group, and 5 in the MCI group. Also, a 50% accuracy response rate cut-off 
was applied for all load condition on non-match trials collapsed into one variable. These cut-
off criteria were not so strict as to leave out all of the extreme scores, but stricter cut-off 
criteria would leave out important patient data, as most of the outliers were in the MCI-patient 
group and could therefore be considered valuable data. For recruitment procedures, inclusion 
and exclusion criteria, informed consents, ethical approval, DNA extraction and genotyping, 
see study 1. 
5.2.3 Statistical Analysis 
To get an account of the effect of normal aging, and MCI on different match measures, 
participants were divided into three subgroups: young control (YC): 19 – 45 years, N = 89 for 
match analysis, N = 91 for non-match analysis, old control (OC): 46 – 81 years, N = 219 for 
match analysis, N = 216 for non-match analysis, and MCI-group: 46 – 77 years, N = 45 for 
match analysis, N = 47 for non-match analysis. Participants were also splittet according to 
their genotype, leaving six groups; YC÷ε4 (N=57/59), YC+ε4 (N=32/32), OC÷ε4 
(N=137/137), OC+ε4 (N=82/79), MCI÷ε4 (N=27/27), MCI+ε4 (N=18/20).  
Mean accuracy response rate for target dot location was the measure of interest, and 
submitted for each condition in omnibus, repeated measures ANOVAs. Memory Load (one, 
two, or three target dots) and Target Distance (match, non-match close distance, non-match 
medium distance, non-match long distance) were within-subject factors, but  because previous 
studies had found APOE effects when analyzing match conditions separate from non-match 
condition (Greenwood, Lambert, et al., 2005), the same separate omnibus ANOVA procedure 
for match trials and non-match trials was adopted. Thus Memory Load (3) and Target 
Distance (1 level for match-analysis, 3 levels for non-match analysis) were submitted as 
within-subject factors, and Group (YC, OC, MCI) and APOE (non-carriers , ε4-carriers) as 
between subject factors in two different omnibus ANOVAs. 
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A follow-up omnibus ANOVA for healthy age groups was conducted for both match 
and non-match trials, to get more detailed information about normal age related decline, and 
to check for possible APOE modulation in healthy age group. This procedure excluded the 
MCI group, and applied the same 50% cut-off score criteria. The remaining 314 participant 
were divided in three subgroups (Young Age (YA): 22.1 – 47.8 years, N=103, Middle Age 
(MA): 48.2 – 63.07 years, N=104, Old Age (OA): 63.21 – 81 years, N=100). The distribution 
of participants in normal age and APOE groups were as following: YA÷ε4 (N=66), YA+ε4 
(N=37), MA÷ε4 (N=69), MA+ε4 (N=35), OA÷ε4 (N=61), OA+ε4 (N=39). 
Also in this analysis, we did follow up omnibus repeated measure ANCOVAs with 
gender as a covariate (male = 236, female = 128) for both match and non-match trials, to 
control for possible biases related to gender distribution. 
5.3 Results 
Match trials. Omnibus ANOVA on match trials revealed a rather strong main effect of 
Memory Load, F(2,347) = 157.37, p < .0005, η²p = .312, indicating that when memory load 
increased, accuracy declined (.88 for one dot, .76 for two dots, .75 for three dots). This pattern 
was the same for all participants under all conditions, as no interactions with any of the 
between-subject factors were revealed. A main effect of Group was only marginal significant 
(p = 0.79), and no effects of APOE were found. 
Non-match trials. The analysis revealed a main effect of Group, F(2,358) = 14.73, p < 
.0005, η²p = .078, indicating that accuracy rate declined with age, and due to MCI. YC had the 
highest correct responses rate (M = .83), MCI the lowest correct response rate (M = .75) and 
OC an intermediate value (M = .79), see figure 4.1. APOE was not involved in any of the non-
match conditions, as no main or interaction effects with APOE were found.  
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Figure 4.1 Main effect Group on non-match trials 
 
The analysis showed a main effect of Memory Load, F(2,716) = 155.27, p < .0005, η²p 
= .309, accuracy being highest for 1 dot condition (M = .85) lowest for three dot condition (M 
= .75) and in between value found in two dots condition (M = .79). A strong main effect of 
Target Distance was also found, F(2,716) = 1322.3, p < .0005, η²p = .746. Accuracy rate was 
highest for non-match long distance (M = .96), second highest for non-match medium 
distance (M = .85) and lowest for non-match close distance (M = .572). The effect of Distance 
was modulated by Load, as indicated by the Load × Distance interaction, F(4,1432) = 50.764, 
p < .0005, η²p = .127. Accuracy rates generally declined when Load increased except for long 
distance condition which stayed on a 96% accuracy rate. As memory load increased, accuracy 
declined for all other distance condition, and was lowest for non-match close distance in 3-dot 
load condition (M = .49). Thus, when memory load was high, and the distance between target 
and test dot was small, accuracy fell to a 50-50 chance level.  
Group did modulate the effect of Distance, F(4,716) = 8.647, p < .005, η²p = .047, and 
was also involved in a two way interaction with Load, F(4,716), p = .023, η²p = .017. Figure 
4.2 shows that the decline in accuracy due to shorter test-target distance was proportional in 
the following manner: YC < OC < MCI, with MCI qualifying the largest effect. A similar 
steady decline in accuracy due to increase of Memory Load for all groups was found (see 
figure 4.3). Together, this shows that MCI diagnosis affects working memory measures of 
load demand and distance demand in a way that seems additive to the effect of normal aging. 
No significant effects of APOE or any other interactions were revealed in this analysis.  
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Figure 4.2 Distance × Group interaction 
 
Figure 4.3 Load × Group interaction 
 
Healthy age analysis. Because of the steady decline YC < OC < MCI on both Load 
and Distance conditions, the development of accuracy scores in normal aging groups was 
examined in greater detail. This analysis revealed similar patterns as the former. On match 
trials an expected main effect of Load was found, F(2,301) = 174.96, p < .0005, η²p = .368, 
but no other effects were revealed. A main effect of Age Group was not significant (p = .084). 
On non-match trials, expected strong main effects of Load , F(2,602) = 275.29, p < .0005, η²p 
= .747, Distance, F(2,602) = 1700.9, p < .0005, η²p = .85, and Age Group were revealed , 
F(2,301) = 15.148, p < .0005, η²p = .091. Distance had the strongest effect and explained most 
of the total variation between groups (85%), accuracy being lowest for close distance non-
match (M = .58), highest for long distance non-match (M = .969) and intermediate for 
medium distance non-match (M = .865). The main effect of Load exhibited a similar pattern 
to the former analysis, and figure 4.4 visualizes the main effect of Age Group, indicating a 
steady decline in accuracy due to age.  
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Figure 4.4 Main effect Age Group 
 
The effect of Distance was modulated by Age Group, F(4,602) = 11, p < .0005, η²p = 
.068, showing that only the oldest age group fell to a chance level on close non-match 
distance condition. The effect of  Distance was also modulated by Load, F(4,1204) = 83, p < 
.0005 η²p = .216. Load was modulated by Age Group, F(4,602) = 2.634, p = .039, η²p = .017, 
and the three-way interaction Distance × Load × Age Group, F(8,1204) = 2.585, p = .018, η²p 
= .017, indicated that the age effect on Distance was further modulated by Load, but no 
eminent pattern could be seen. No interactions with APOE were found in any of the possible 
interactions. Figure 4.5 summarizes the main effects of four healthy age groups and MCI.  
Figure 4.5 Mean Accuracy for all groups 
 
Gender covariate follow up. On match trials, gender was not involved (p’s > .819). On 
non-match trails, gender interacted with Distance, F(2,720) = 4.287, p = .026, η²p = .012, 
indicating that accuracy rate for men fell more rapid due to shortening of distance than 
women. However, overall pattern of response did not alter much due to gender covariate 
involvement.  
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5.4 Discussion 
As expected, results showed that accuracy declined due to load increase for all groups. 
The results also found an expected decline in accuracy when distance between cue and target 
on non-match conditions became smaller. Distance and Load also interacted, indicating that 
the highest demand situation (3 dots, non-match close distance) was difficult for all groups. 
When demand on both dimensions was maximized, performance declined to a chance level 
for all groups.  
Because this experiment did not involve any manipulations that can be associated with 
activation of the attentional reorienting system, we did not expect to find specific interaction 
effects between MCI and APOE+ε4 on any of these measures. A main effect of Group was 
predicted, leading to an additive effect of MCI. It was found that Group did not affect match 
conditions, but a linear decline in non-match conditions were found for both Distance and 
Load on non-match conditions. When comparing overall accuracy response rates in healthy 
age control groups with MCI accuracy rate, a clear pattern of steady decline due to age and 
MCI was indicated (see figure 4.5). Thus, when load and resolution demands were 
manipulated, visuospatial working memory performance fell due to age, and MCI.  The 
pattern of decline between healthy control groups and the MCI that was proportional, 
indicating a quantitatively difference. APOE was not involved in healthy age groups or in the 
MCI group. This indicates that pathological aging factor may reflect an acceleration of normal 
aging on visuospatial working memory performances, a pattern consistent with our prediction, 
as manipulations in the current experiment are not believed to activate the attentional 
reorienting system.  
Based on previous findings, modulations of APOE were predicted, especially in the 
healthy control group. Findings in the current experiment contradicted studies that have found 
APOE modulations in healthy individuals on different working memory tasks like response 
inhibition (Reinvang, Winjevoll, et al., 2010) and more executive components of working 
memory (Rosen, Bergeson, Putnam, Harwell, & Sunderland, 2002). A previous study by 
Greenwood et al. (2005) also found subtle APOE modulations using the same visuospatial 
working memory paradigm as the one used in the current study. As mentioned in the 
methodology section, the separate match vs. non-match analysis were based on Greenwood et 
al.s (2005) procedures. They analyzed match and non-match trials separately, and found that 
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accuracy scores of homozygote ε4 carrier were significantly lower than non-carriers in three 
dot load condition in match conditions. Greenwood et al. (2005) tested participants on other 
measures as well, and found that healthy middle-aged APOEε4-carriers exhibited deficits on 
both visuospatial attentional orienting (similar to the current experiment 1) and tasks where 
spatial location working memory and attention interacted, but point out that APOE affected 
brain areas modulating working memory less than it affected brain areas modulating 
visuospatial attention (Greenwood, Lambert, et al., 2005).  
Why were no APOE modulations found in the current study? Some of the 
inconsistency between results in Experiment 1, 2 and 3 may be because different 
neurophysiologic systems are involved when attentional reorienting and visuospatial working 
memory are measured. Previous studies have indicate that the cholinergic system modulates 
attention, and noradrenergic and dopaminergic system modulated functions of working 
memory (Greenwood, et al., 2008). In the current experiment, working memory was 
measured on two visuospatial dimensions with different types of demand (load, distance). It 
may be that these manipulations are not sensitive to attentional processes, and this may in turn 
explain some of the missing APOE modulation. It has been proposed that APOE modulations 
are more consistent on integrity of the attentional system, whereas the integrity of working 
memory is less affected by the inheritance of an ε4 allele (Greenwood, Lambert, et al., 2005). 
Results from Greenwood et al. (2005) indicate that the ability to retain memory for location 
was reduced for the homozygote ε4-carrier in a much more subtle way than in measures of 
attentional reorienting. Further, as areas of the parietal lobe modulate attentional processes 
(Corbetta, Kincade, Ollinger, McAvoy, & Shulman, 2000), and AD is a disease associated 
with insults in the medial temporal and parietal lobe (Possin, 2010), and because APOE may 
be involved with cholinergic systems integrity declines with age (Reinvang, Lundervold, 
Wehling, Rootwelt, & Espeseth, 2010), one may assume lower effects of APOE on tests 
where attentional demands are low. However, the relationship between APOE and the 
cholinergic system is not yet well understood (Parasuraman, et al., 2002).  
Another possible explanation why no APOE effects were found similar to Greenwood 
et al.s (2005) findings, may be due to different recruitment procedures, the fact that APOE 
interacts with many other factors before affecting cognition (Mahley, 2006; Parasuraman, et 
al., 2002; Reinvang, Lundervold, et al., 2010), but also the fact that the working memory 
stimuli paradigm measured accuracy response rate, while the visuospatial attention stimuli 
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paradigm measured reaction time. Maybe processing speed measures in experiment 1 & 2 are 
more sensitive to genetic modulations than accuracy measures? Further, the third experiment 
was difficult (some outliers accuracy scores near zero), and because these outliers were 
excluded, one may ask if this excluded the effects of APOE as well. APOE effects in the 
former experiments were found in the MCI group, and used as an indication of increased risk 
for AD. The MCI+ε4 groups were small, N = 27 in experiment 1, N = 21 in experiment 2, and 
N = 18 on match-trials in the current experiment. Maybe the low scores of the excluded 
patients were due to genuine effects of APOE? However, a final effort to explain the absence 
of an APOE × MCI interaction is consistent with our prediction; i.e. measures in this 
experiment did not activate the attentional reorienting system. 
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6 General discussion 
The aim of this thesis was to examine how age, MCI and APOE influenced age-related 
decline in cognitive control functions. It was believed that specific measures of cognitive 
control were sensitive to distinguish incipient AD-development from normal aging processes. 
In terms of current methodology, it was hypothesized that interactive effects of MCI and 
APOEε4 would lead to non-additive response patterns only on measures of the attentional 
reorienting system.  
The results of this study gave evidence to support this hypothesis, as additive effects 
of MCI and no APOE modulations were found on tests not believed to activate the attentional 
reorienting system, i.e. all psychometric test scores (study 1), measures of visuospatial 
working memory (experiment 3), and performance on goal maintenance tasks following a 
valid cue (valid arrow in experiment 1 & AX trials in experiment 2) On these measures MCI 
accelerated the effect of normal aging in a quantitative way, a pattern consistent with the 
unitary factor framework that claims only one underlying factor contributing to pathological 
and normal aging, and that functional impairments associated with dementia reflects an 
acceleration of impairments that are found in normal aging (Buckner, 2004). Some of these 
results may also be understood in context of compensation and cognitive reserve theories. 
Compensation and cognitive reserve theories assume that alternative brain network 
recruitment, and cognitive strategies usage, may explain why neurological decline in the brain 
not fully can predict the variability in older peoples cognitive performance (Stern, 2002, 
2003). The underrecruitment hypothesis claims that age-related decline is due to restriction in 
the availability of frontal resources, as these resources only will be elicited under certain 
conditions. (Logan, Sanders, Snyder, Morris, & Buckner, 2002). In conditions like high 
attentional demanding situations, older people benefit more from task strategy cues than 
younger people (Logan, et al., 2002). These external cues, or environmental support, 
contribute to improve the performances of older adults (Buckner, 2004; Logan, et al., 2002). 
The observed increase of Benefit in experiment 1, and unaffected AX trial scores in the MCI 
group in experiment 3 may indicate that older people used compensating strategies to meet 
with their deficits (general slowing being their deficit). Both a valid cue arrow, and an A 
before X can be seen as environmental support, as the cues were frequent and predictive. 
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Thus, one may assume that older individuals in the current study used environmental support 
strategies to compensate for age related decline in processing speed to improve performance.  
On trials expected to activate the attentional reorienting system, current results suggest 
that MCI diagnosis in combination with APOEε4 resulted in a non-additive effect. These 
measures were RTs after invalid arrow cue in the visuospatial reorienting task, and RTs after 
BX trials in the contextual updating task. Specifically, our results showed a “sudden” increase 
in Cost RT and BX RT in the MCI+ε4 group only. These patterns of response were 
interpreted as non-additive, because they indicated something different from an additive 
increase of age-related decline. The MCI÷ε4 group exhibited such an additive decline on 
these measures, but not the MCI+ε4 group. Non-additive response patterns of MCI+ε4 are 
consistent with the multiple factor framework claiming that different factors target different 
brain regions in pathology and normal aging, thus leading to different pattern of impairment 
(Buckner, 2004). According to Buckner (2004) medial-temporal areas are typically affected 
by AD-processes, whereas frontal-stratial areas are typically affected by normal aging 
processes. However, this does not mean that both areas can’t be affected at the same time 
(Buckner, 2004). Buckner (2004) claims that processes leading to normal and pathological 
aging are in principal different processes, but may easily occur together, leading to severe 
cognitive decline. Can one assumed that the MCI+ε4 group is affected by both normal age-
related and pathological aging processes? Are they more affected by pathological aging 
processes than the MCI÷ε4 group? Our results are consistent with the general believe that 
APOEε4 increases the risk for AD-development in people with MCI (Wang, et al., 2010), and 
may thus indicate that areas of both dorsal and ventral frontoparietal regions are affected in 
the prodromal AD-development. The next section will argue that measures of invalid arrow 
cues and BX-trials are sensitive to impairments in the attentional reorienting system by 
describing how BX-trials and invalid cues activate the same underlying neurological circuits, 
before turning to evidence supporting the idea that aspects of the attentional reorienting 
system are specifically impaired in early AD. 
6.1.1 Are measures of invalid arrow cues and BX-trials sensitive to 
impairments in the Attentional Reorienting System? 
Neuroimaging studies indicate that the dorsal network is a control mechanism during 
ongoing behavior that send out top-down information to bias appropriate stimuli features and 
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location of stimuli (Corbetta, et al., 2008). The ventral frontoparietal network is independent 
of the dorsal network, but breaks the circuit and interrupts dorsal regions when a salient or 
behaviorally relevant stimuli outside the site of attention is detected and requires response 
(Corbetta, et al., 2008). Thus, reorienting of attention may in a neurophysiologic sense be 
understood in terms of the effectiveness of the ventral network output on interrupting ongoing 
activity in the dorsal network. But, how can one argue that invalid arrow cues and BX-trials 
will elicit this interaction between ventral and dorsal frontoparietal networks? 
In the first experiment, the target letter was the stimuli that required action. To be able 
to respond to the target letter after an invalid cue, the person had to reorient his/her attention 
from the one side of the visual field to the other (Posner, 1980). Because most cues were 
valid, one may expect that a frequent valid arrow engages the dorsal network to pay attention 
on one side of the visual field. When however the target letter appeared on the other side, one 
may expect the ventral system to disrupt the dorsal network, and attention must be reoriented 
to the other side of the visual field. It can be assume that similar process are engaged in the 
AX-CPT task, even though this is a non-spatial task. Participants are required to reorient their 
attention internally, and respond according to context information (to respond to X only after 
an A). A valid AX trial is the most frequent trial and will biasing attention towards a specific 
response pattern. On BX trials, the B cue will bias the participants response to expect a non-
X, thus probably engaging the dorsal network. When however the letter X appears, the 
participant must reorient attention to context information and make the correct response. 
Thus, one may assume that the letter X after B is an unexpected, but behaviorally relevant 
target that will activate the ventral network and break the ongoing circuit in the dorsal 
network.  
As mentioned above, there is converging evidence from neuroimaging studies that 
both the dorsal system and the ventral systems interact when attention is reoriented by a novel 
and behaviorally relevant stimuli (Corbetta, et al., 2008). This has been replicated in many 
studies, for instance a fMRI study found activation of the ventral attention system in a spatial 
cueing paradigm based on Posners (1980), when both horizontal and vertical axes were 
implemented as directions of orienting, indicating that the ventral network is not limited to 
horizontal orienting tasks (Macaluso & Patria, 2007).  Also in “signal-driven reorienting”, 
that is when behaviorally irrelevant objects that share features with the relevant target, as in 
the oddball paradigm, the ventral system is involved (Espeseth, et al., in press).  Other ventral 
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and dorsal reorienting network recruitments are described, for instance the temporoparietal 
juncion (TPJ), and the basal ganglia + frontal insula areas that are respectively recruited when 
attention shifts occurred from spatially, or when attentional reorienting occurred unexpected 
(Shulman et al., 2009). Studies on the AX-CPT task have found that the prefrontal cortex 
(PFC), and dopamine projections into the PFC are involved in a fMRI study involving 41 
healthy adults ranging from age 18 – 83 (Braver & Barch, 2002) On visuospatial reorienting, 
the cholinergic system is believed to be involved (Parasuraman, et al., 2002). Inferior parts of 
the parietal cortex are in a fMRI study found to be involved in the disengagement of 
visuospatial attention (Corbetta, et al., 2000), and insults in the parietal cortex are also found 
to impair disengagement of visuospatial attention (Posner, et al., 1984). Further, the 
cholinergic system integrity seems to be important for an effective parietal mediation of the 
attentional tasks (Everitt & Robbins, 1997), and age associated decline in top-down 
attentional function may be due to deregulations and decline in the integrity of the cholinergic 
system (Sarter & Bruno, 2004). Also, a PET study measuring acetylcholinesterase activity in 
different cortical regions found a significant reduction of this activity in the parietal cortex in 
AD patients when compared with healthy control (Iyo et al., 1997).  
Evidence supporting the idea of the ventral network as a protective filter in 
distinguishing relevant from non-relevant stimuli come from neuroimaging studies where 
internally and externally directed processes are examined. Internally directed processing, 
referred to as the default system is activated when no environmental stimuli require attention 
(Raichle & Snyder, 2007). The default system is believed to be mediated by similar areas as 
the dorsal attentional network (Corbetta, et al., 2008), i.e. medialfrontal, temporoparietal areas 
and areas around the posterior cingulate cortex (Raichle & Snyder, 2007; Schilbach, Eickhoff, 
Rotarska-Jagiela, Fink, & Vogeley, 2008) One hypothesis describes the default network as 
functional opposite of the dorsal attention network which directs attention towards 
environmental perception and action (Corbetta, et al., 2008), and is activated/deactivated by 
the absence/presence of external cues (Raichle & Snyder, 2007). As these dorsal attention 
system and the default system are believed to interact, reorienting is described as a process 
where the ventral frontoparietal network initiate a switch between internal and external 
systems. In this context the ventral network is believed to filter out which stimuli one should 
response to. An impairment in this system may lead to involuntarily reorienting between 
internal and external systems, for instance to reorient toward the environment when one is 
acquired to engage in self-referential thoughts (Corbetta, et al., 2008). Consistent with this 
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view, a suboptimal ventral network function will cause decline in attentional reorienting 
function. Results in the current study revealed a non-additive decline in the attentional 
reorienting function in the MCI+ε4 group only. There is reason to believe that people with 
early AD have functional impairments associated with ventral and the dorsal networks. For 
instance, several studies have indicated that the default system is impaired in people with 
MCI and further in people with AD, probably because of amyloid plaque deposits (Buckner, 
Andrews-Hanna, & Schacter, 2008; Buckner et al., 2005; Greicius, Srivastava, Reiss, & 
Menon, 2004; Rombouts, Barkhof, Goekoop, Stam, & Scheltens, 2005). Parasuraman et al. 
(1992) found specific AD-related impairments on invalid arrow cues, while Braver et al. 
(2005) found AD-related impairments on BX-trials. Taken together, this indicates that the 
observed decline in the MCI+ε4 group may reflect deficits in the ventral and dorsal 
frontoparietal networks, leading to the conclusion that the cued discrimination task and AX-
CPT are behavioral assays that, in context of this study and its limitations, may be used to 
detect preclinical AD-development. The next question is if the attentional reorienting system 
may be understood as a possible endophenotype candidate linking APOE to AD? 
6.1.2 The Attentional Reorienting System as an Endophenotype for 
Alzheimer’s Disease?  
Endophenotyping is used as a strategy to track effects of genetic variability on 
different mediating neuronal mechanisms (phenotypes), that link the gap between DNA 
sequence and pathology (Meyer-Lindenberg & Weinberger, 2006). Phenotypic parameters 
can ranging from molecular effects, neurobiochemistry, endocrinological, neuroanatomical, 
electrophysiology, to neuropsychological behavioral effects (Espeseth, et al., in press; Meyer-
Lindenberg & Weinberger, 2006). Gottesman and Gould (2003) proposed several criteria for 
an endophenotype. An  endophenotype has to be associated with illness in the population, to 
be heritable, and to be state independent (Gottesman & Gould, 2003). Further, as the 
endophenotype has to be associated with illness, Gottesman and Gould (2003) also claim that 
it has occur at higher rates in non-affected family members (for instant siblings of the affected 
family member) than in the general population. But there are few endophenotypes that 
actually fulfill all criteria, and the more behaviorally the phenotype, the smaller will the 
expected effect of a gene be (Meyer-Lindenberg & Weinberger, 2006). As we propose a 
neuropsychological endophenotype, one may not expect great genetic effects on the 
attentional reorienting system. In the current study, results on attentional reorienting measures 
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that involved MCI and APOE found partial eta squared’s (η²p) between .001 (for Cost RTs) 
and .027 (for Condition-RTs), thus explaining between .1 – 2.7 % of total variability on these 
measures. This is generally considered as small effect sizes. For APOE main effects partial eta 
squared’s were between .007 (for Cost Effect) and .012 (for Condition). However, one may 
argue that standard of the first criteria are met (the illness criteria), as attentional reorienting 
selectively was impaired for individuals at high risk for AD-development. To meet standards 
of the last criteria, one should include performance of different family members in the 
MCI+ε4 group to see if they have a more similar attentional reorienting impairment compared 
to the general population. This was not part of the current design. Besides, there does not exist 
standardized scores (as in a psychometric test) for measures of the attentional reorienting 
system. However, if one assumes attentional reorienting impairments is to be heritable, effects 
of APOEε4 are only expected in people who are at risk for developing AD. We found initial 
evidence for this as normal age group performance were not impaired or affected by APOE. 
But, to meet full standard of heritability, twin/adoption studies should be conducted. Meyer-
Lindenberg & Weinberger (2006) mention another criteria specific for a behavioral 
endophenotype is that the chosen behavioral assay must activate neural circuits that are 
plausibly translating genetic protein expressions to behavior. As mentioned above, 
neuroimaging, and neuropsychological studies support the view that an invalid arrow and BX 
trials activate ventral and dorsal frontoparietal networks. Taken together, there may be enough 
evidence to consider the attentional reorienting function as a candidate for APOE-AD 
endophenotype.  
6.1.3 Limitations 
Several limitations in this study may however affect the presented conclusion. For 
instance, the current study’s clinical focus did not distinguish between AD and other possible 
forms of dementia that people in the MCI group may develop. Thus, one can not exclude the 
possibility that pathological processes leading to other forms of dementia affected 
performance in the MCI+ε4 group, even though AD is most prevalent dementia disease 
(Fratiglioni et al., 1991), and APOE generally is believed to be a risk gene for AD (Mahley, 
2006). Second, the MCI diagnosis is a highly heterogeneous diagnosis, ranging from 
subjective complaints to accumulation of gross functional and structural impairments 
(Grambaite, et al., 2011; Grambaite et al., 2010; Petersen, et al., 2001), and some MCI-
patients may remain stable(sMCI), and not develop AD (Vannini, et al., 2007). Thus an 
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unified group performance in the MCI group is unlikely to be expected. Also, it is known that 
pathological changes associated with amyloid deposits and neurofibrillary tangle appear early 
in development of AD (Braak & Braak, 1991), long before neuropsychological functions are 
affected (Parasuraman, et al., 2002), and we simply don’t not know if people in our the old 
control group and MCI group overlapped according to neuropathological burden development 
in the brain. Thus, the clear distinction the current study design made between normal and 
pathological aging groups may in fact be unclear and mashed, and one cannot exclude the 
possibility that some of the 414 “healthy” participants in the OC group may be in a preclinical 
AD phase. Thus, if APOE modulation on attentional reorienting is to be understood as a 
preclinical AD endophenotype, one would expect to find APOE effect in the OC group as 
well.  
Other limitations are concerned with the studies cross sectional design. A longitudinal 
design would give more information about possible cohort effects on these measures. Also, 
the modulation path between APOE and cholinergic network integrity are not fully 
understood, and further molecular genetic studies are needed to determine underlying 
mechanisms for how protein products of APOE polymorphisms modulate cholinergic 
transmissions to the posterior parietal cortex (Parasuraman, et al., 2002), and how the 
attentional reorienting system in involved in this context. Small et al. (2004) claim that when 
analyzing the effect of APOE on cognitive performance, several factors may cause 
inconsistent results. For instance the fact that the base rate of the APOEε4-allele is small 
(14%) in comparison with APOEε3 (78%) and APOEε2-alleles (8%), may contribute to a lack 
of APOE effect on different cognitive performance (Small, et al., 2004). In the first 
experiment 27 participants belonged to the MCI+ε4 group, and in the second experiment the 
number of participants in the MCI+ε4 group was 21. This small sample size may exaggerate 
the effect of pathological aging. Also, as mentioned before, the ε4-allele increases the risk for 
developing AD, but the potency of this risk declines after a certain age (Breitner, et al., 1999). 
APOE seem to affect cognitive performance differently in different time of age (Mondadori, 
et al., 2007; Turic, et al., 2001).  
In sum, even though we found evidence that measures of the attentional reorienting 
system were specifically impaired in the AD-high risk group (MCI+ε4), there are limitations 
to the generality of these findings. 
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6.2 Summary 
The current study investigated the effects of normal aging, MCI and modulations of 
APOE on different measures of cognitive control, as cognitive control functions were 
believed to be sensitive for early AD-detection. Participants were tested on a wide specter of 
attentional and executive working memory control functions, measuring response on different 
distracter manipulations, context information manipulation, spatial resolution and load 
manipulations, using reaction time and accuracy rates, spatial and non-spatial measures, 
visual and auditory stimuli. We predicted to find non-additive effects on measures that 
activate the attentional reorienting system, and found support for this hypothesis, as only RTs 
after invalid arrow cues in experiment 1, and BX trials in experiment 2 involved an 
interaction between MCI and APOEε4. Further, these interactions resulted in a qualitative 
difference between the MCI+ε4 group and age-matched control, indicating that these 
measures may be sensitive for prodromal AD-development. On measures of visuospatial 
working memory and psychometric tests, no effects of APOE were found, and patients with 
MCI and age-matched control group differed only quantitatively, indicating MCI accelerated 
functional decline associated with normal aging in this measure. Because BX trials and 
invalid arrow cue involved unexpected but behaviorally relevant targets, it was claimed that 
these measures are aspects of the same function which involves both dorsal and ventral 
frontoparietal networks, as described by Corbetta et al. (2008). Possibilities to view the 
attentional reorienting system as a candidate for a neuropsychological endophenotype being 
an intermediate step in the APOE-AD association were discussed according to criteria for 
endophenotypes. Finally, several limitations with this study were presented, like the absence 
of longitudinal follow up analysis, a possible inclusion of pre-clinical people with dementia in 
the control group, heterogeneousity in the MCI group, or small sample size in some analysis.  
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